Document:

<PAGE>

                                                                    EXHIBIT 4.32

                                                                  EXECUTION COPY

================================================================================

                               PURCHASE AGREEMENT

                                      among

                                 PXRE GROUP LTD.

                              PXRE CAPITAL TRUST VI

                                       and

                               DEKANIA CDO I, LTD.

                                ----------------

                          Dated as of November 6, 2003

                                ----------------

===============================================================================

<PAGE>

                                                                  EXECUTION COPY

                               PURCHASE AGREEMENT
                    ($10,000.000 Trust Preferred Securities)

         THIS PURCHASE AGREEMENT, dated as of November 6, 2003 (this "Purchase
Agreement"), is entered into among PXRE Group Ltd., a Bermuda company (the
"Company"), and PXRE Capital Trust VI, a Delaware statutory trust (the "Trust",
and together with the Company, the "Sellers"), and Dekania CDO I, Ltd., a
company with limited liability established under the laws of the Cayman Islands,
or its assignee. (the "Purchaser").

                                   WITNESSETH:

         WHEREAS, the Sellers propose to issue and sell ten thousand (10,000)
Floating Rate Preferred Securities of the Trust, having a stated liquidation
amount of $1,000 per security, bearing a fixed interest rate of 7.58% through
the interest payment date in November 2008, and thereafter a variable rate,
reset quarterly, equal to LIBOR (as defined in the Indenture (as defined below))
plus 3.90%; (the "Preferred Securities");

         WHEREAS, the Preferred Securities will be guaranteed by the Company
(the "Guarantee") pursuant to the Guarantee Agreement (the "Guarantee
Agreement"), dated as of the Closing Date (defined below), and executed and
delivered by the Company and JPMorgan Chase Bank, a New York banking
corporation, as trustee (in such capacity, the "Guarantee Trustee"), for the
benefit of the holders from time to time of the Preferred Securities;

         WHEREAS, the entire proceeds from the sale of the Preferred Securities
will be combined with the entire proceeds from the sale by the Trust to the
Company of its common securities (the "Common Securities"), and will be used by
the Trust to purchase Ten Million Three Hundred Ten Thousand Dollars
($10,310,000) in principal amount of the unsecured junior subordinated
deferrable interest notes of the Company (the "Junior Subordinated Notes");

         WHEREAS, the Preferred Securities and the Common Securities for the
Trust will be issued pursuant to the Amended and Restated Trust Agreement (the
"Trust Agreement"), dated as of the Closing Date, among the Company, as
depositor, JPMorgan Chase Bank, a New York banking corporation, as property
trustee (in such capacity, the "Property Trustee"), Chase Manhattan Bank USA,
National Association, a national banking association, as Delaware trustee (in
such capacity, the "Delaware Trustee"), the Administrative Trustees named
therein (in such capacities, the "Administrative Trustees") and the holders from
time to time of undivided beneficial interests in the assets of the Trust; and

         WHEREAS, the Junior Subordinated Notes will be issued pursuant to a
Junior Subordinated Indenture, dated as of the Closing Date (the "Indenture"),
between the Company and JPMorgan Chase Bank, a New York banking corporation, as
indenture trustee (in such capacity, the "Indenture Trustee").

<PAGE>

         NOW, THEREFORE, in consideration of the mutual agreements and subject
to the terms and conditions herein set forth, the parties hereto agree as
follows:

         1. Definitions. The Preferred Securities, the Common Securities and the
Junior Subordinated Notes are collectively referred to herein as the
"Securities." This Purchase Agreement, the Indenture, the Trust Agreement, the
Guarantee Agreement and the Securities are collectively referred to herein as
the "Operative Documents." All other capitalized terms used but not defined in
this Purchase Agreement shall have the respective meanings ascribed thereto in
the Indenture.

         2. Purchase and Sale of the Preferred Securities.

         (a) The Sellers agree to sell to the Purchaser, and the Purchaser
agrees to purchase from the Sellers the Preferred Securities for an amount (the
"Purchase Price") equal to Ten Million Dollars ($10,000,000). The Purchaser
shall be responsible for the rating agency costs and expenses. The Sellers shall
use the Purchase Price, together with the proceeds from the sale of the Common
Securities, to purchase the Junior Subordinated Notes.

         (b) Delivery or transfer of, and payment for, the Preferred Securities
shall be made at 10:00 A.M. Chicago time (11:00 A.M. New York time), on November
6, 2003 or such later date (not later than December 6, 2003 (30 days later)) as
the parties may designate (such date and time of delivery and payment for the
Preferred Securities being herein called the "Closing Date"). The Preferred
Securities shall be transferred and delivered to the Purchaser against the
payment of the Purchase Price to the Sellers made by wire transfer in
immediately available funds on the Closing Date to a U.S. account designated in
writing by the Company at least two business days prior to the Closing Date.

         (c) Delivery of the Preferred Securities shall be made at such
location, and in such names and denominations, as the Purchaser shall designate
at least two business days in advance of the Closing Date. The Company and the
Trust agree to have the Preferred Securities available for inspection and
checking by the Purchaser in Chicago, Illinois, not later than 1:00 P.M.,
Chicago time (2:00 P.M. New York time), on the business day prior to the Closing
Date. The closing for the purchase and sale of the Preferred Securities shall
occur at the offices of Mayer, Brown, Rowe & Maw LLP, 190 South LaSalle Street,
Chicago, Illinois 60603, or such other place as the parties hereto shall agree.

         3. Conditions. The obligations of the parties under this Purchase
Agreement are subject to the following conditions:

         (a) the representations and warranties contained herein shall be
accurate as of the date of delivery of the Preferred Securities.

         (b) Reserved.

                                       3
<PAGE>

         (c) Morgan Lewis & Bockius, LLP, Chancery Chambers and Conyers Dill &
Pearman, special Bermuda counsel for the Company (the "Company Counsel"), shall
have delivered an opinion, dated the Closing Date, addressed to the Purchaser
and JPMorgan Chase Bank, in substantially the form set out in Annex A-I, A-II
and A-III respectively hereto and (ii) the Company shall have furnished to the
Purchaser the opinion of the Company's General Counsel or a certificate signed
by the Company's Chief Executive Officer, President or an Executive Vice
President, Chief Financial Officer, Treasurer or Assistant Treasurer, dated the
Closing Date, addressed to the Purchaser, in substantially the form set out in
Annex A-IV hereto. In rendering their opinion, the Company Counsel may rely as
to factual matters upon certificates or other documents furnished by officers,
directors and trustees of the Company and the Trust and by government officials
(provided, however, that copies of any such certificates or documents are
delivered to the Purchaser) and by and upon such other documents as such counsel
may, in their reasonable opinion, deem appropriate as a basis for the Company
Counsel's opinion. The Company Counsel may specify the jurisdictions in which
they are admitted to practice and that they are not admitted to practice in any
other jurisdiction and are not experts in the law of any other jurisdiction. If
the Company Counsel is not admitted to practice in the State of New York, the
opinion of the Company Counsel may assume, for purposes of the opinion, that the
laws of the State of New York are substantively identical, in all respects
material to the opinion, to the internal laws of the state in which such counsel
is admitted to practice. Such Company Counsel Opinion shall not state that they
are to be governed or qualified by, or that they are otherwise subject to, any
treatise, written policy or other document relating to legal opinions,
including, without limitation, the Legal Opinion Accord of the ABA Section of
Business Law (1991).

         (d) The Purchaser shall have been furnished the opinion of Mayer,
Brown, Rowe & Maw LLP, special tax counsel for the Purchaser, dated the Closing
Date, addressed to the Purchaser and JPMorgan Chase Bank, in substantially the
form set out in Annex B hereto.

         (e) The Purchaser shall have received the opinion of Richards, Layton &
Finger, P.A., special Delaware counsel for the Purchaser and the Delaware
Trustee, dated the Closing Date, addressed to the Purchaser, JPMorgan Chase
Bank, the Delaware Trustee and the Company, in substantially the form set out in
Annex C hereto.

         (f) The Purchaser shall have received the opinion of Locke Liddell &
Sapp LLP, special counsel for the Guarantee Trustee, the Property Trustee and
the Indenture Trustee, dated the Closing Date, addressed to the Purchaser, in
substantially the form set out in Annex D hereto.

         (g) The Purchaser shall have received the opinion of Richards, Layton &
Finger, P.A., special Delaware counsel for the Purchaser and the Delaware
Trustee, dated the Closing Date, addressed to the Purchaser and JPMorgan Chase
Bank, in substantially the form set out in Annex E hereto.

         (h) The Company shall have furnished to the Purchaser a certificate of
the Company, signed by the Chief Executive Officer, President or an Executive
Vice President and by the Chief Financial Officer, Treasurer or Assistant
Treasurer of the Company, and the Trust shall have furnished to the Purchaser a
certificate of the Trust, signed by an Administrative Trustee of the Trust, in
each case dated the Closing Date, and, in the case of the Company, as to (i) and
(ii) below and, in the case of the Trust, as to (i) below.

                                       4
<PAGE>

                  (i) the representations and warranties in this Purchase
         Agreement are true and correct on and as of the Closing Date with the
         same effect as if made on the Closing Date, and the Company and the
         Trust have complied with all the agreements and satisfied all the
         conditions on either of their part to be performed or satisfied at or
         prior to the Closing Date; and

                  (ii) since the date of the Interim Financial Statements (as
         defined below), there has been no material adverse change in the
         condition (financial or other), earnings, business or assets of the
         Company and its subsidiaries, whether or not arising from transactions
         occurring in the ordinary course of business.

         (i) Subsequent to the execution of this Purchase Agreement, there shall
not have been any change, or any development involving a prospective change, in
or affecting the condition (financial or other), earnings, business or assets of
the Company and its subsidiaries, whether or not occurring in the ordinary
course of business, the effect of which is, in the Purchaser's reasonable
judgment, so material and adverse as to make it impractical or inadvisable to
proceed with the purchase of the Preferred Securities.

         (j) Prior to the Closing Date, the Company and the Trust shall have
furnished to the Purchaser and its counsel such further information,
certificates and documents as the Purchaser or its counsel may reasonably
request.

         If any of the conditions specified in this Section 3 shall not have
been fulfilled when and as provided in this Purchase Agreement, or if any of the
opinions, certificates and documents mentioned above or elsewhere in this
Purchase Agreement shall not be reasonably satisfactory in form and substance to
the Purchaser or its counsel, this Purchase Agreement and all the Purchaser's
obligations hereunder may be canceled at, or at any time prior to, the Closing
Date by the Purchaser. Notice of such cancellation shall be given to the Company
and the Trust in writing or by telephone or facsimile confirmed in writing.

         Each certificate signed by any trustee of the Trust or any officer of
the Company and delivered to the Purchaser or the Purchaser's counsel in
connection with the Operative Documents and the transactions contemplated hereby
and thereby shall be deemed to be a representation and warranty of the Trust
and/or the Company, as the case may be, and not by such trustee or officer in
any individual capacity.

         4. Representations and Warranties of the Company and the Trust. The
Company and the Trust jointly and severally represent and warrant to, and agree
with the Purchaser, as follows:

         (a) Neither the Company nor the Trust, nor any of their "Affiliates"
(as defined in Rule 501(b) of Regulation D ("Regulation D") under the Securities
Act (as defined below)), nor any person acting on its or their behalf (other
than the Purchaser, as to whom the Company and the Trust make no
representation), has, directly or indirectly, made offers or sales of any
security, or solicited offers to buy any security, under circumstances that
would require the registration of any of the Securities under the Securities Act
of 1933, as amended (the "Securities Act").

                                       5
<PAGE>

         (b) Neither the Company nor the Trust, nor any of their Affiliates, nor
any person acting on its or their behalf (other than the Purchaser, as to whom
the Company and the Trust make no representation), has engaged in any form of
general solicitation or general advertising (within the meaning of Regulation D)
in connection with any offer or sale of any of the Securities.

         (c) The Securities (i) are not and have not been listed on a national
securities exchange registered under section 6 of the Securities Exchange Act of
1934, as amended (the "Exchange Act"), or quoted on a U.S. automated
inter-dealer quotation system and (ii) are not of an open-end investment
company, unit investment trust or face-amount certificate company that are, or
are required to be, registered under section 8 of the Investment Company Act of
1940, as amended (the "Investment Company Act"), and the Securities otherwise
satisfy the eligibility requirements of Rule 144A(d)(3) promulgated pursuant to
the Securities Act ("Rule 144A(d)(3)").

         (d) Neither the Company nor the Trust, nor any of their Affiliates, nor
any person acting on its or their behalf, has engaged, or will engage, in any
"directed selling efforts" within the meaning of Regulation S under the
Securities Act with respect to the Securities.

         (e) Neither the Company nor the Trust is, and, immediately following
consummation of the transactions contemplated hereby and the application of the
net proceeds therefrom, will not be, an "investment company" or an entity
"controlled" by an "investment company," in each case within the meaning of
section 3(a) of the Investment Company Act. The Company is not engaged in the
"investment business" as defined in The Investment Business Act of 1998.

         (f) Neither the Company nor the Trust has paid or agreed to pay to any
person any compensation for soliciting another to purchase any of the
Securities, except for the Preferred Securities Commission and/or the sales
commission the Company has agreed to pay to Dekania Capital Management, LLC (or
to the Company's introducing agent on behalf of Dekania Capital Management LLC)
pursuant to the letter agreement between the Company and Dekania Capital
Management, LLC, dated October 15, 2003.

         (g) The Trust has been duly created and is validly existing in good
standing as a statutory trust under the Delaware Statutory Trust Act, 12 Del. C.
ss.3801, et seq. (the "Statutory Trust Act") with all requisite power and
authority to own property and to conduct the business it transacts and proposes
to transact and to enter into and perform its obligations under the Operative
Documents to which it is a party. The Trust is duly qualified to transact
business as a foreign entity and is in good standing in each jurisdiction in
which such qualification is necessary, except where the failure to so qualify or
be in good standing would not have a material adverse effect on the condition
(financial or otherwise), earnings, business or assets of the Trust, whether or
not occurring in the ordinary course of business. The Trust is not a party to or
otherwise bound by any agreement other than the Operative Documents. The Trust
is and will be, under current law, classified for federal income tax purposes as
a grantor trust and not as an association or publicly traded partnership taxable
as a corporation.

                                       6
<PAGE>

         (h) The Trust Agreement has been duly authorized by the Company and, on
the Closing Date specified in Section 2(b), will have been duly executed and
delivered by the Company and the Administrative Trustees of the Trust, and,
assuming due authorization, execution and delivery by the Property Trustee and
the Delaware Trustee, will be a legal, valid and binding obligation of the
Company and the Administrative Trustees, enforceable against them in accordance
with its terms, subject to applicable bankruptcy, insolvency and similar laws
affecting creditors' rights generally and to general principles of equity. Each
of the Administrative Trustees of the Trust is an employee of the Company or one
of its subsidiary insurance companies and has been duly authorized by the
Company to execute and deliver the Trust Agreement.

         (i) Each of the Guarantee Agreement and the Indenture has been duly
authorized by the Company and, on the Closing Date, will have been duly executed
and delivered by the Company, and, assuming due authorization, execution and
delivery by the Guarantee Trustee, in the case of the Guarantee Agreement, and
by the Indenture Trustee, in the case of the Indenture, will be a legal, valid
and binding obligation of the Company enforceable against it in accordance with
its terms, subject to applicable bankruptcy, insolvency and similar laws
affecting creditors' rights generally and to general principles of equity.

         (j) The Preferred Securities and the Common Securities have been duly
authorized by the Trust and, when issued and delivered against payment therefor
on the Closing Date in accordance with this Purchase Agreement, in the case of
the Preferred Securities, and in accordance with the Common Securities
Subscription Agreement, in the case of the Common Securities, will be validly
issued, fully paid and non-assessable and will represent undivided beneficial
interests in the assets of the Trust entitled to the benefits of the Trust
Agreement, enforceable against the Trust in accordance with their terms, subject
to applicable bankruptcy, insolvency and similar laws affecting creditors'
rights generally and to general principles of equity. The issuance of the
Securities is not subject to any preemptive or other similar rights. On the
Closing Date, all of the issued and outstanding Common Securities will be
directly owned by the Company free and clear of any pledge, security interest,
claim, lien or other encumbrance of any kind (each, a "Lien").

         (k) The Junior Subordinated Notes have been duly authorized by the
Company and, on the Closing Date, will have been duly executed and delivered to
the Indenture Trustee for authentication in accordance with the Indenture and,
when authenticated in the manner provided for in the Indenture and delivered to
the Trust against payment therefor in accordance with the Junior Subordinated
Note Purchase Agreement, will constitute legal, valid and binding obligations of
the Company entitled to the benefits of the Indenture, enforceable against the
Company in accordance with their terms, subject to applicable bankruptcy,
insolvency and similar laws affecting creditors' rights generally and to general
principles of equity.

                                       7
<PAGE>

         (l) This Purchase Agreement has been duly authorized, executed and
delivered by the Company and the Trust.

         (m) Neither the issue and sale of the Common Securities, the Preferred
Securities or the Junior Subordinated Notes, nor the purchase of the Junior
Subordinated Notes by the Trust, nor the execution and delivery of and
compliance with the Operative Documents by the Company or the Trust, nor the
consummation of the transactions contemplated herein or therein, (i) will
conflict with or constitute a violation or breach of the Trust Agreement or the
charter or bylaws of the Company or any subsidiary of the Company or any
applicable law, statute, rule, regulation, judgment, order, writ or decree of
any government, governmental authority, agency or instrumentality or court,
domestic or foreign, having jurisdiction over the Trust or the Company or any of
its subsidiaries or their respective properties or assets (collectively, the
"Governmental Entities"), (ii) will conflict with or constitute a violation or
breach of, or a default or Repayment Event (as defined below) under, or result
in the creation or imposition of any Lien upon any property or assets of the
Trust, the Company or any of the Company's subsidiaries pursuant to, any
contract, indenture, mortgage, loan agreement, note, lease or other agreement or
instrument to which (A) the Trust, the Company or any of its subsidiaries is a
party or by which it or any of them may be bound, or (B) to which any of the
property or assets of any of them is subject, or any judgment, order or decree
of any court, governmental authority or arbitrator, except, in the case of this
clause (ii), for such conflicts, breaches, violations, defaults, Repayment
Events (as defined below) or Liens which (X) would not, singly or in the
aggregate, adversely affect the consummation of the transactions contemplated by
the Operative Documents and (Y) would not, singly or in the aggregate, have a
material adverse effect on the condition (financial or otherwise), earnings,
business, liabilities and assets (taken as a whole) or business prospects of the
Company and its subsidiaries taken as a whole, whether or not occurring in the
ordinary course of business (a "Material Adverse Effect") or (iii) require the
consent, approval, authorization or order of any court or Governmental Entity
other than those that have been obtained. As used herein, a "Repayment Event"
means any event or condition which gives the holder of any note, debenture or
other evidence of indebtedness (or any person acting on such holder's behalf)
the right to require the repurchase, redemption or repayment of all or a portion
of such indebtedness by the Trust or the Company or any of its subsidiaries
prior to its scheduled maturity.

         (n) The Company has been duly incorporated and is validly existing as a
company in good standing under the laws of Bermuda, with all requisite corporate
power and authority to own, lease and operate its properties and conduct the
business it transacts and proposes to transact, and is duly qualified to
transact business and is in good standing as a foreign corporation in each
jurisdiction where the nature of its activities requires such qualification,
except where the failure of the Company to be so qualified would not, singly or
in the aggregate, have a Material Adverse Effect.

         (o) The Company has no subsidiaries that are material to its business,
financial condition or earnings other than those subsidiaries listed in Schedule
1 attached hereto (collectively, the "Significant Subsidiaries"). Each
Significant Subsidiary has been duly incorporated and is validly existing as a
corporation in good standing under the laws of the jurisdiction in which it is
chartered or organized, with all requisite corporate power and authority to own,
lease and operate its properties and conduct the business it transacts and
proposes to transact. Each Significant Subsidiary is duly qualified to transact
business and is in good standing as a foreign corporation in each jurisdiction
where the nature of its activities requires such qualification, except where the
failure to be so qualified would not, singly or in the aggregate, have a
Material Adverse Effect.

                                       8
<PAGE>

         (p) Each of the Trust, the Company and each of the Company's
subsidiaries hold all necessary approvals, authorizations, orders, licenses,
consents, registrations, qualifications, certificates and permits (including,
without limitation, insurance licenses from the insurance departments of the
various states and jurisdictions where the Company's insurance subsidiaries
write insurance business or otherwise conduct insurance or reinsurance business,
as the case may be, or as may be required by any applicable insurance statutes
of such states or other jurisdictions (collectively, the "Insurance Licenses"))
(collectively, including the Insurance Licenses, the "Government Licenses") of
and from Governmental Entities necessary to conduct their respective businesses
as now being conducted, and neither the Trust, the Company nor any of the
Company's subsidiaries has received any notice of proceedings relating to the
revocation or modification of any such Government License, except where the
failure to be so licensed or approved or the receipt of an unfavorable decision,
ruling or finding, would not, singly or in the aggregate, have a Material
Adverse Effect; all of the Governmental Licenses are valid and in full force and
effect, except where the invalidity or the failure of such Governmental Licenses
to be in full force and effect, would not, singly or in the aggregate, have a
Material Adverse Effect; and the Company and its subsidiaries are in compliance
with all applicable laws, rules, regulations, judgments, orders, decrees and
consents, except where the failure to be in compliance would not, singly or in
the aggregate, have a Material Adverse Effect.

         (q) All of the issued and outstanding shares of share capital or
capital stock of the Company, each of its Significant Subsidiaries and its
subsidiary insurance companies (such subsidiaries, collectively, the "Applicable
Subsidiaries") are validly issued, fully paid and non-assessable; all of the
issued and outstanding capital stock of the Applicable Subsidiaries of the
Company is owned by the Company, directly or through subsidiaries, free and
clear of any Lien, claim or equitable right; and none of the issued and
outstanding capital stock of the Company or any of the Applicable Subsidiaries
was issued in violation of any preemptive or similar rights arising by operation
of law, under the charter or by-laws of such entity or under any agreement to
which the Company or any the Applicable Subsidiaries is a party.

         (r) Neither the Company nor any of its subsidiaries is (i) in violation
of its respective charter or by-laws or similar organizational documents or (ii)
in default in the performance or observance of any obligation, agreement,
covenant or condition contained in any contract, indenture, mortgage, loan
agreement, note, lease or other agreement or instrument to which the Company or
any such subsidiary is a party or by which it or any of them may be bound or to
which any of the property or assets of any of them is subject, except, in the
case of clause (ii), where such violation or default would not, singly or in the
aggregate, have a Material Adverse Effect.

         (s) Except as provided in Schedule 2 attached hereto ("Material
Litigation"), there is no action, suit or proceeding before or by any
Governmental Entity, arbitrator or court, domestic or foreign, now pending or,
to the knowledge of the Company or the Trust after due inquiry, threatened
against or affecting the Trust or the Company or any of the Company's
subsidiaries, except for such actions, suits or proceedings that, if adversely
determined, would not, singly or in the aggregate, adversely affect the
consummation of the transactions contemplated by the Operative Documents or have
a Material Adverse Effect; and except for Material Litigation, the aggregate of
all pending legal or governmental proceedings to which the Trust or the Company
or any of its subsidiaries is a party or of which any of their respective
properties or assets is subject, including ordinary routine litigation
incidental to the business, are not expected to result in a Material Adverse
Effect.

                                       9
<PAGE>

         (t) The accountants of the Company who certified the Financial
Statements (as defined below) are independent public accountants of the Company
and its subsidiaries within the meaning of the Securities Act, and the rules and
regulations of the Securities and Exchange Commission (the "Commission")
thereunder.

         (u) The audited consolidated financial statements (including the notes
thereto) and schedules of the Company and its consolidated subsidiaries for the
fiscal year ended December 31, 2002 (the "Financial Statements") and the interim
unaudited consolidated financial statements of the Company and its consolidated
subsidiaries for the quarter ended June 30, 2003 (the "Interim Financial
Statements") provided to the Purchaser are the most recent available audited and
unaudited consolidated financial statements of the Company and its consolidated
subsidiaries, respectively, and fairly present in all material respects, in
accordance with U.S. generally accepted accounting principles, the financial
position of the Company and its consolidated subsidiaries, and the results of
operations and changes in financial condition as of the dates and for the
periods therein specified, subject, in the case of Interim Financial Statements,
to year-end adjustments (which are expected to consist solely of normal
recurring adjustments). Such consolidated financial statements and schedules
have been prepared in accordance with U.S. generally accepted accounting
principles ("GAAP")consistently applied throughout the periods involved (except
as otherwise noted therein).

         (v) The statutory financial statements dated as of December 31, 2002
and June 30, 2003 (the "Statutory Financial Statements") of each of the
Company's U.S. insurance company subsidiaries have, for each relevant period,
been prepared in accordance with statutory accounting principles ("SAP")
prescribed or permitted by the National Association of Insurance Commissioners,
and with respect to each insurance company subsidiary, the appropriate insurance
department of the state of domicile of such insurance company subsidiary, and
such accounting practices have been applied on a consistent basis throughout the
periods involved (whether GAAP or SAP, as applicable, the "Applicable Accounting
Principles").

         (w) None of the Trust, the Company nor any of its subsidiaries has any
material liability, whether known or unknown, whether asserted or unasserted,
whether absolute or contingent, whether accrued or unaccrued, whether liquidated
or unliquidated, and whether due or to become due, including any liability for
taxes (and there is no past or present fact, situation, circumstance, condition
or other basis for any present or future action, suit, proceeding, hearing,
charge, complaint, claim or demand against the Company or its subsidiaries that
could give rise to any such liability), except for (i) liabilities set forth in
the Financial Statements, the Interim Financial Statements, Statutory Financial
Statements or any 1934 Act Report (as defined below) and (ii) normal
fluctuations in the amount of the liabilities referred to in clause (i) above
occurring in the ordinary course of business of the Trust, the Company and all
of its subsidiaries since the date of the most recent balance sheet included in
such Financial Statements.

                                       10
<PAGE>

         (x) None of the Company or any of its subsidiaries has been requested
by a Governmental Entity to republish, restate, or refile, in any material
respect, any regulatory or financial report in the last three years, except as
listed on Schedule 3 attached hereto.

         (y) Since the respective dates of the Financial Statements, Interim
Financial Statements, Statutory Financial Statements and the Regulatory Reports,
there has not been (A) any material adverse change or development with respect
to the condition (financial or otherwise), earnings, business, assets or
business prospects of the Company and its subsidiaries, taken as a whole,
whether or not occurring in the ordinary course of business or (B) any dividend
or distribution of any kind declared, paid or made by the Company on any class
of its share capital other than regular quarterly dividends on the Company's
common or preferred shares.

         (z) The authorized capitalization of the Company and its subsidiary
insurance companies are as set forth in the Financial Statements, the Interim
Financial Statements, the Statutory Financial Statements and Regulatory Reports
and meet all applicable regulatory requirements with respect thereto.

         (aa) The documents of the Company filed with the Commission in
accordance with the Exchange Act, from and including the commencement of the
fiscal year covered by the Company's most recent Annual Report on Form 10-K, at
the time they were or hereafter are filed by the Company with the Commission
(collectively, the "1934 Act Reports"), complied and will comply in all material
respects with the requirements of the Exchange Act and the rules and regulations
of the Commission thereunder as of the date of filing (the "1934 Act
Regulations"), and, at the date of this Purchase Agreement and on the Closing
Date, do not and will not include an untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were
made, not misleading; and other than such instruments, agreements, contracts and
other documents as are filed as exhibits to the Company's Annual Report on Form
10-K, Quarterly Reports on Form 10-Q or Current Reports on Form 8-K, there are
no instruments, agreements, contracts or documents of a character described in
Item 601 of Regulation S-K promulgated by the Commission to which the Company or
any of its subsidiaries is a party. The Company is in compliance with all
currently applicable requirements of the Exchange Act that were added by the
Sarbanes-Oxley Act of 2002.

                                       11
<PAGE>

         (bb) None of the Trust, the Company nor any of its subsidiaries, or any
of their respective officers, directors, employees or representatives, is
subject or is party to, or has received any notice from any Regulatory Agency
(as defined below) that any of them will become subject or party to any
investigation with respect to, any cease-and-desist order, agreement, civil
monetary penalty, consent agreement, memorandum of understanding or other
regulatory enforcement action, proceeding or order with or by, or is a party to
any commitment letter or similar undertaking to, or is subject to any directive
by, or has been a recipient of any supervisory letter from, or has adopted any
board resolutions at the request of, any Regulatory Agency that, in any such
case, currently restricts in any material respect the conduct of their business
or that in any material manner relates to their capital adequacy, capital
reserves, their marketing or sales practices, their ability or authority to pay
dividends or make distributions to their shareholders or make payments of
principal or interest on their debt obligations, their management or their
business (each, a "Regulatory Action"), nor has the Trust, the Company or any of
its subsidiaries been advised by any Regulatory Agency that it is considering
issuing or requesting any such Regulatory Action; and there is no unresolved
violation, criticism or exception by any Regulatory Agency with respect to any
report or statement relating to any examinations of the Trust, the Company or
any of its subsidiaries, except where such unresolved violation, criticism or
exception would not, singly or in the aggregate, have a Material Adverse Effect.
As used herein, the term "Regulatory Agency" means any federal or state agency
charged with the supervision or regulation of insurance companies or holding
companies of insurance companies, or engaged in the insurance of insurance
company reserves, or any court, administrative agency or commission or other
governmental agency, authority or instrumentality having supervisory or
regulatory authority with respect to the Trust, the Company or any of its
subsidiaries.

         (cc) No labor dispute with the employees of the Trust, the Company or
any of its subsidiaries exists or, to the knowledge of the executive officers of
the Trust or the Company, is imminent, except those which would not, singly or
in the aggregate, have a Material Adverse Effect.

         (dd) No filing with, or authorization, approval, consent, license,
order, registration, qualification or decree of, any Governmental Entity, other
than those that have been made or obtained, is necessary or required for the
performance by the Trust or the Company of their respective obligations under
the Operative Documents, as applicable, or the consummation by the Trust and the
Company of the transactions contemplated by the Operative Documents.

         (ee) Each of the Trust, the Company and each subsidiary of the Company
has good and marketable title to all of its respective real and personal
properties, in each case free and clear of all Liens and defects, except for
those that would not, singly or in the aggregate, have a Material Adverse
Effect; and all of the leases and subleases under which the Trust, the Company
or any subsidiary of the Company holds properties are in full force and effect,
except where the failure of such leases and subleases to be in full force and
effect would not, singly or in the aggregate, have a Material Adverse Effect,
and none of the Trust, the Company or any subsidiary of the Company has any
notice of any claim of any sort that has been asserted by anyone adverse to the
rights of the Trust, the Company or any subsidiary of the Company under any such
leases or subleases, or affecting or questioning the rights of such entity to
the continued possession of the leased or subleased premises under any such
lease or sublease, except for such claims that would not, singly or in the
aggregate, have a Material Adverse Effect.

                                       12
<PAGE>

         (ff) The Company has no present intention to exercise its option to
defer payments of interest on the Junior Subordinated Notes as provided in the
Indenture. The Company believes that the likelihood that it would exercise its
rights to defer payments of interest on the Junior Subordinated Notes as
provided in the Indenture at any time during which the Junior Subordinated Notes
are outstanding is remote because, among other things, of the restrictions that
would be imposed on the Company's ability to declare or pay dividends or
distributions on, or to redeem, purchase, acquire or make a liquidation payment
with respect to, any of the Company's capital stock and on the Company's ability
to make any payments of principal, interest or premium, if any, on, or repay,
repurchase or redeem, any of its debt securities that rank pari passu in all
respects with or junior in interest to the Junior Subordinated Notes.

         (gg) The information provided by the Company and the Trust pursuant to
this Purchase Agreement does not, as of the date hereof, and will not, as of the
Closing Date, contain any untrue statement of a material fact or omit to state
any material fact necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading.

         5. Representations and Warranties of the Purchaser. The Purchaser
represents and warrants to, and agrees with, the Company and the Trust as
follows:

         (a) The Purchaser is aware that the Securities have not been and will
not be registered under the Securities Act and may not be offered or sold within
the United States or to "U.S. persons" (as defined in Regulation S under the
Securities Act) except in accordance with Rule 903 of Regulation S under the
Securities Act or pursuant to an exemption from the registration requirements of
the Securities Act.

         (b) The Purchaser is an "accredited investor," as such term is defined
in Rule 501(a) of Regulation D under the Securities Act.

         (c) Neither the Purchaser, nor any of the Purchaser's affiliates, nor
any person acting on the Purchaser's or the Purchaser's Affiliate's behalf has
engaged, or will engage, in any form of "general solicitation or general
advertising" (within the meaning of Regulation D under the Securities Act) in
connection with any offer or sale of the Preferred Securities.

         6. Agreements of the Company and the Trust. The Company and the Trust
jointly and severally agree with the Purchaser as follows:

         (a) During the period from the date of this Agreement to the Closing
Date, the Company and the Trust shall use their best efforts and take all action
necessary or appropriate to cause their representations and warranties contained
in Section 4 hereof to be true as of the Closing Date, after giving effect to
the transactions contemplated by this Purchase Agreement, as if made on and as
of the Closing Date.

         (b) The Company and the Trust will arrange for the qualification of the
Preferred Securities for sale under the laws of such jurisdictions as the
Purchaser may designate and will maintain such qualifications in effect so long
as required for the sale of the Preferred Securities. The Company or the Trust,
as the case may be, will promptly advise the Purchaser of the receipt by the
Company or the Trust, as the case may be, of any notification with respect to
the suspension of the qualification of the Preferred Securities for sale in any
jurisdiction or the initiation or threatening of any proceeding for such
purpose.

                                       13
<PAGE>

         (c) Neither the Company nor the Trust will, nor will either of them
permit any of its Affiliates to, nor will either of them permit any person
acting on its or their behalf (other than the Purchaser) to, resell any
Preferred Securities that have been acquired by any of them.

         (d) Neither the Company nor the Trust will, nor will either of them
permit any of their Affiliates or any person acting on their behalf to, engage
in any "directed selling efforts" within the meaning of Regulation S under the
Securities Act with respect to the Securities.

         (e) Neither the Company nor the Trust will, nor will either of them
permit any of their Affiliates or any person acting on their behalf (other than
the Purchaser) to, directly or indirectly, make offers or sales of any security,
or solicit offers to buy any security, under circumstances that would require
the registration of any of the Securities under the Securities Act.

         (f) Neither the Company nor the Trust will, nor will either of them
permit any of its Affiliates or any person acting on their behalf (other than
the Purchaser) to, engage in any form of "general solicitation or general
advertising" (within the meaning of Regulation D) in connection with any offer
or sale of the any of the Securities.

         (g) So long as any of the Securities are outstanding, (i) the
Securities shall not be listed on a national securities exchange registered
under section 6 of the Exchange Act or quoted in a U.S. automated inter-dealer
quotation system and (ii) neither the Company nor the Trust shall be an open-end
investment company, unit investment trust or face-amount certificate company
that is, or is required to be, registered under section 8 of the Investment
Company Act, and, the Securities shall otherwise satisfy the eligibility
requirements of Rule 144A(d)(3).

         (h) Each of the Company and the Trust shall furnish to (i) the holders,
and subsequent holders of the Preferred Securities, (ii) Dekania Capital
Management, LLC (at 1818 Market Street, 28th Floor, Philadelphia, Pennsylvania
19013, or such other address as designated by Dekania Capital Management, LLC)
and (iii) any beneficial owner of the Securities reasonably identified to the
Company and the Trust (which identification may be made by either such
beneficial owner or by Dekania Capital Management, LLC), a duly completed and
executed certificate in the form attached hereto as Annex F, including the
financial statements referenced in such Annex, which certificate and financial
statements shall be so furnished by the Company and the Trust not later than
forty five (45) days after the end of each of the first three fiscal quarters of
each fiscal year of the Company and not later than ninety (90) days after the
end of each fiscal year of the Company. The Company must provide such
certificate and financial information for all of its insurance subsidiary
companies, except for PXRE Reinsurance (Barbados) Ltd. and PXRE Limited;
provided, however, if either PXRE Reinsurance (Barbados) Ltd. or PXRE Limited
engages in insurance activity, which insurance activity exceeds 10% of the
aggregate net earned premium of the Company and its consolidated subsidiaries as
a whole in any fiscal year, the entity exceeding the 10% threshold will, from
that point forward, be required to furnish the Officer's Financial Certificate
and financial information pursuant to Annex F.

                                       14
<PAGE>

         (i) Each of the Company and the Trust will, during any period in which
it is not subject to and in compliance with section 13 or 15(d) of the Exchange
Act, or it is not exempt from such reporting requirements pursuant to and in
compliance with Rule 12g3-2(b) under the Exchange Act, shall provide to each
holder of the Securities and to each prospective purchaser (as designated by
such holder) of the Securities, upon the request of such holder or prospective
purchaser, any information required to be provided by Rule 144A(d)(4) under the
Securities Act. If the Company and the Trust are required to register under the
Exchange Act, such reports filed in compliance with Rule 12g3-2(b) shall be
sufficient information as required above. This covenant is intended to be for
the benefit of the Purchaser, the holders of the Securities, and the prospective
purchasers designated by the Purchaser and such holders, from time to time, of
the Securities.

         (j) Neither the Company nor the Trust will, until one hundred eighty
(180) days following the Closing Date, without the Purchaser's prior written
consent, offer, sell, contract to sell, grant any option to purchase or
otherwise dispose of, directly or indirectly, (i) any Preferred Securities or
other securities of the Trust other than as contemplated by this Purchase
Agreement or (ii) any other securities convertible into, or exercisable or
exchangeable for, any Preferred Securities or other securities of the Trust.

         7. Payment of Expenses. The Company, as depositor of the Trust, agrees
to pay all costs and expenses incident to the performance of the obligations of
the Company and the Trust under this Purchase Agreement, whether or not the
transactions contemplated herein are consummated or this Purchase Agreement is
terminated, including all costs and expenses incident to (i) the authorization,
issuance, sale and delivery of the Preferred Securities and any taxes payable in
connection therewith; (ii) the fees and expenses of qualifying the Preferred
Securities under the securities laws of the several jurisdictions as provided in
Section 6(b); (iii) the fees and expenses of the counsel, the accountants and
any other experts or advisors retained by the Company or the Trust; (iv) the
fees and all reasonable expenses of the Guarantee Trustee, the Property Trustee,
the Delaware Trustee, the Indenture Trustee and any other trustee or paying
agent appointed under the Operative Documents, including the fees and
disbursements of counsel for such trustees, which fees shall not exceed a $1,250
acceptance fee and $3,000 in administrative fees annually; (v) the fees and all
reasonable expenses of Richards, Layton & Finger, P.A., special Delaware counsel
retained by the Purchaser and the Delaware Trustee, which fees and expenses
shall not exceed $3500; and (vi) the fees and all reasonable expenses of Mayer,
Brown, Rowe & Maw LLP, special counsel retained by the Purchaser, which fees and
expenses shall not exceed $30,000.

         If the sale of the Preferred Securities provided for in this Purchase
Agreement is not consummated because any condition set forth in Section 3 hereof
to be satisfied by either the Company or the Trust is not satisfied, because
this Purchase Agreement is terminated pursuant to Section 9 or because of any
failure, refusal or inability on the part of the Company or the Trust to perform
all obligations and satisfy all conditions on its part to be performed or
satisfied hereunder other than by a reason of a default by the Purchaser, the
Company will reimburse the Purchaser upon demand for all reasonable
out-of-pocket expenses (including the fees and expenses of each of the
Purchaser's counsel specified in subparagraphs (v) and (vi) of the immediately
preceding paragraph) that shall have been incurred by the Purchaser in
connection with the proposed purchase and sale of the Preferred Securities. The
Company shall not in any event be liable to the Purchaser for the loss of
anticipated profits from the transactions contemplated by this Purchase
Agreement.

                                       15
<PAGE>

         8. Indemnification. (a) The Company and the Trust agree jointly and
severally to indemnify and hold harmless the Purchaser, the Purchaser's
affiliates, Dekania Capital Management, LLC (collectively, the "Indemnified
Parties") and the Indemnified Parties' respective directors, officers, employees
and agents and each person who "controls" the Indemnified Parties within the
meaning of either the Securities Act or the Exchange Act against any and all
losses, claims, damages or liabilities, joint or several, to which they or any
of them may become subject under the Securities Act, the Exchange Act or other
federal or state statutory law or regulation, at common law or otherwise,
insofar as such losses, claims, damages or liabilities (or actions in respect
thereof) arise out of or are based upon (i) any untrue statement or alleged
untrue statement of a material fact contained in any information or documents
furnished or made available to the Purchaser by or on behalf of the Company,
(ii) the omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not misleading
or (iii) the breach or alleged breach of any representation, warranty or
agreement of either Seller contained herein, and agrees to reimburse each such
Indemnified Party, as incurred, for any legal or other expenses reasonably
incurred by them in connection with investigating or defending any such loss,
claim, damage, liability or action. This indemnity agreement will be in addition
to any liability which the Company or the Trust may otherwise have.

         (b) The Company agrees to indemnify the Trust against all loss,
liability, claim, damage and expense whatsoever due from the Trust under
paragraph (a) above.

         (c) Promptly after receipt by an Indemnified Party under this Section 8
of notice of the commencement of any action, such Indemnified Party will, if a
claim in respect thereof is to be made against the indemnifying party under this
Section 8, promptly notify the indemnifying party in writing of the commencement
thereof; but the failure so to notify the indemnifying party (i) will not
relieve the indemnifying party from liability under paragraph (a) above unless
and to the extent that such failure results in the forfeiture by the
indemnifying party of material rights and defenses and (ii) will not, in any
event, relieve the indemnifying party from any obligations to any Indemnified
Party other than the indemnification obligation provided in paragraph (a) above.
Purchaser shall be entitled to appoint counsel to represent the Indemnified
Party in any action for which indemnification is sought. An indemnifying party
may participate at its own expense in the defense of any such action; provided,
that counsel to the indemnifying party shall not (except with the consent of the
Indemnified Party) also be counsel to the Indemnified Party. In no event shall
the indemnifying parties be liable for fees and expenses of more than one
counsel (in addition to any local counsel) separate from their own counsel for
all Indemnified Parties in connection with any one action or separate but
similar or related actions in the same jurisdiction arising out of the same
general allegations or circumstances. An indemnifying party will not, without
the prior written consent of the Indemnified Parties, settle or compromise or
consent to the entry of any judgment with respect to any pending or threatened
claim, action, suit or proceeding in respect of which indemnification may be
sought hereunder (whether or not the Indemnified Parties are actual or potential
parties to such claim, action, suit or proceeding) unless such settlement,
compromise or consent includes an unconditional release of each Indemnified
Party from all liability arising out of such claim, action, suit or proceeding.

                                       16
<PAGE>
         9. Termination. This Purchase Agreement shall be subject to termination
in the absolute discretion of the Purchaser, by notice given to the Company and
the Trust prior to delivery of and payment for the Preferred Securities, if
prior to such time (i) a downgrading shall have occurred in the rating accorded
the Company's debt securities or preferred stock by any "nationally recognized
statistical rating organization," as that term is used by the Commission in Rule
15c3-1(c)(2)(vi)(F) under the Exchange Act, or such organization shall have
publicly announced that it has under surveillance or review, with possible
negative implications, its rating of the Company's debt securities or preferred
stock, (ii) the Trust shall be unable to sell and deliver to the Purchaser at
least $10,000,000 stated liquidation value of Preferred Securities, (iii) the
Company or any of its subsidiaries that is an insurance company shall cease to
be "adequately-capitalized" under the statutes, rules, regulations, codes or
ordinances of any Regulatory Agency within the meaning of any applicable
regulations of any Regulations Agency, or any formal administrative or judicial
action is taken by any appropriate state or federal insurance regulator against
the Company or of its subsidiary insurance companies for unsafe and unsound
insurance practices, or violations of law, (iv) a suspension or material
limitation in trading in securities generally shall have occurred on the New
York Stock Exchange, (v) a suspension or material limitation in trading in any
of the Company's securities shall have occurred on the exchange or quotation
system upon which the Company' securities are traded, if any, (vi) a general
moratorium on commercial insurance activities shall have been declared either by
federal, Connecticut or Bermuda authorities or (vii) there shall have occurred
any outbreak or escalation of hostilities, or declaration by the United States
of a national emergency or war or other calamity or crisis the effect of which
on financial markets is such as to make it, in the Purchaser's judgment,
impracticable or inadvisable to proceed with the offering or delivery of the
Preferred Securities.

         10. Representations and Indemnities to Survive. The respective
agreements, representations, warranties, indemnities and other statements of the
Company and the Trust or their respective officers or trustees and of the
Purchaser set forth in or made pursuant to this Purchase Agreement will remain
in full force and effect, regardless of any investigation made by or on behalf
of the Purchaser, the Company or the Trust or any of the their respective
officers, directors, trustees or controlling persons, and will survive delivery
of and payment for the Preferred Securities. The provisions of Sections 7 and 8
shall survive the termination or cancellation of this Purchase Agreement.

         11. Amendments. This Purchase Agreement may not be modified, amended,
altered or supplemented, except upon the execution and delivery of a written
agreement by each of the parties hereto.

                                       17
<PAGE>

         12. Notices. All communications hereunder will be in writing and
effective only on receipt, and, if sent to the Purchaser, will be mailed,
delivered by hand or courier or sent by facsimile and confirmed to the Purchaser
c/o Dekania Capital Management, LLC, 1818 Market Street, 28th Floor,
Philadelphia, Pennsylvania 19106, Attention: Adam Schneider, Facsimile: (215)
861-7700; with a copy to Mayer, Brown, Rowe & Maw LLP, 190 South LaSalle Street,
Chicago, Illinois 60603, Attention: J. Paul Forrester, Facsimile: (312) 701-7711
or other address as the Purchaser shall designate for such purpose in a notice
to the Company and the Trust; and if sent to the Company or the Trust, will be
mailed, delivered by hand or courier or sent by facsimile and confirmed to it at
PXRE Group Ltd., Swan Building, 26 Victoria Street, Hamilton, HM 12, Bermuda,
Attention: Chief Financial Officer, Facsimile: (441) 296-6162 with a copy to
Morgan Lewis & Bockis LLP, 101 Park Avenue, New York, New York 10178, Attention:
Richard Petretti.

         13. Successors and Assigns. This Purchase Agreement will inure to the
benefit of and be binding upon the parties hereto and their respective
successors and permitted assigns. Nothing expressed or mentioned in this
Purchase Agreement is intended or shall be construed to give any person other
than the parties hereto and the affiliates, directors, officers, employees,
agents and controlling persons referred to in Section 8 hereof and their
successors, assigns, heirs and legal representatives, any right or obligation
hereunder. None of the rights or obligations of the Company or the Trust under
this Purchase Agreement may be assigned, whether by operation of law or
otherwise, without the Purchaser's prior written consent. The rights and
obligations of the Purchaser under this Purchase Agreement may be assigned by
the Purchaser without the Company's or the Trust's consent; provided that the
assignee assumes the obligations of the Purchaser under this Purchase Agreement.

         14. Applicable Law. THIS PURCHASE AGREEMENT WILL BE GOVERNED BY AND
CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAW OF THE STATE OF NEW YORK
WITHOUT REFERENCE TO PRINCIPLES OF CONFLICTS OF LAW (OTHER THAN SECTION 5-1401
OF THE GENERAL OBLIGATIONS LAW).

         15. Submission to Jurisdiction. ANY LEGAL ACTION OR PROCEEDING BY OR
AGAINST ANY PARTY HERETO OR WITH RESPECT TO OR ARISING OUT OF THIS PURCHASE
AGREEMENT MAY BE BROUGHT IN OR REMOVED TO THE COURTS OF THE STATE OF NEW YORK,
IN AND FOR THE COUNTY OF NEW YORK, OR OF THE UNITED STATES OF AMERICA FOR THE
SOUTHERN DISTRICT OF NEW YORK (IN EACH CASE SITTING IN THE BOROUGH OF
MANHATTAN). BY EXECUTION AND DELIVERY OF THIS PURCHASE AGREEMENT, EACH PARTY
ACCEPTS, FOR ITSELF AND IN RESPECT OF ITS PROPERTY, GENERALLY AND
UNCONDITIONALLY, THE JURISDICTION OF THE AFORESAID COURTS (AND COURTS OF APPEALS
THEREFROM) FOR LEGAL PROCEEDINGS ARISING OUT OF OR IN CONNECTION WITH THIS
PURCHASE AGREEMENT.

         16. Counterparts and Facsimile. This Purchase Agreement may be executed
by any one or more of the parties hereto in any number of counterparts, each of
which shall be deemed to be an original, but all such counterparts shall
together constitute one and the same instrument. This Purchase Agreement may be
executed by any one or more of the parties hereto by facsimile.

                                       18
<PAGE>

         IN WITNESS WHEREOF, this Purchase Agreement has been entered into as of
the date first written above.

                           PXRE GROUP LTD.

                           By:      /s/ John Modin
                                  ---------------------------------------------
                                 Name:  John M. Modin
                                 Title:    Chief Financial Officer

                           PXRE CAPITAL TRUST VI

                           By: PXRE GROUP LTD., as Depositor

                                 By:     /s/  John Modin
                                        ---------------------------------------
                                        Name: John M. Modin
                                        Title:   Chief Financial Officer

                           DEKANIA CDO I, LTD.

                           By:     /s/   John Cullinane
                                  ---------------------------------------------
                                  Name:  John Cullinane
                                  Title: Director

                                       19
<PAGE>

                                                                      SCHEDULE 1

                        List of Significant Subsidiaries

PXRE Reinsurance Company
PXRE Reinsurance Ltd.
PXRE Reinsurance (Barbados) Ltd.
PXRE Corporation

                                       20
<PAGE>

                                                                      SCHEDULE 2

                               Material Litigation

         In April 2000, PXRE Reinsurance Company entered into an Aggregate
Excess of Loss Retrocessional Reinsurance Agreement (the "Agreement") with a
U.S. based cedent. In the Agreement, PXRE Reinsurance Company reinsured a
portfolio of treaties (the "Protected Portfolio") underwritten by a former
business unit of the cedent which had been divested. Pursuant to this Agreement,
PXRE Reinsurance Company agreed to indemnify the cedent for losses in excess of
a 75% paid loss ratio on the underlying Protected Portfolio up to a 100% paid
loss ratio, subject to an aggregate limit of liability of $50 million. The
latest loss reports related to the Agreement provided by the cedent forecast an
ultimate net loss ratio in excess of 100%, which could result in a full limit
loss to PXRE Group Ltd.

         In June 2003, PXRE Reinsurance Company performed an audit of the
Protected Portfolio reinsured under the Agreement. As a result of this audit,
management identified problems and believes that the cedent may have breached
its contractual obligations and fiduciary duties under the Agreement. PXRE
Reinsurance Company therefore filed suit against the cedent on July 24, 2003 in
a United States District Court seeking rescission of the Agreement and/or
compensatory and punitive damages.

         Although the ultimate outcome of the litigation cannot presently be
determined, management believes that PXRE Reinsurance Company's claims are
meritorious and intends to vigorously prosecute its suit. As of June 30, 2003,
PXRE Reinsurance Company recorded $34 million of loss reserves related to the
Agreement. If PXRE Reinsurance Company's lawsuit is unsuccessful, it could
potentially incur additional losses under the Agreement of up to $10.4 million
on an after-tax basis.

                                       21
<PAGE>

                                                                      SCHEDULE 3

                        Restatement of Regulatory Report

         The Company restated results for the first quarter of 2001, primarily
to reflect an adjustment in the accounting for two ceded finite contracts
entered into during the first quarter of 2001. This adjustment reflected a
change from reinsurance accounting to deposit accounting, so as to recognize
income related to these contracts over the life of the contracts. This
restatement had the effect of increasing reported revenues for the first quarter
while reducing reported net income. Restated net income for the first quarter of
2001 totaled $3,815,000 or $0.32 per diluted share; whereas PXRE had previously
reported net income of $5,639,000 or $0.47 per diluted share for the first
quarter. In addition to the reduced reported net income on the two ceded finite
transactions, the Company's restated results also include a charge of
approximately $209,000 (after tax), which reflects income of $319,000 (after
tax) for the cumulative effect of adopting Statement of Financial Accounting
Standards No. 133, "Accounting for Derivative Instruments and Hedging
Activities," offset by a charge related to the change in value of derivatives in
the quarter of $528,000 (after tax) recorded in interest expense. Restated
revenues for the first quarter of 2001 totaled $60,170,000 versus the previously
reported amount of $48,156,000."

                                       22
<PAGE>

                                                                       ANNEX A-I

                                             November 6, 2003

Dekania CDO I, Ltd.
c/o Dekania Capital Management, LLC
1818 Market Street, 28th Floor
Philadelphia, PA 19106

JPMorgan Chase Bank
600 Travis, Suite 1150
Houston, Texas 77002
Attention: Institutional Trust Services

Re:      Junior Subordinated Deferrable Interest Notes
         due November 6, 2033, Series E of PXRE Group, Ltd.

Ladies and Gentlemen:

         We have acted as special United States counsel for PXRE Group, Ltd., a
Bermuda company (the "Company") and PXRE Capital Trust VI, a Delaware statutory
trust (the "Trust"), in connection with the issuance by the Company of
$10,310,000 aggregate principal amount of its junior subordinated deferrable
interest notes (the "Notes") and the issuance by the Trust of 10,000 Preferred
Securities (liquidation amount of $1,000 per security) of the Trust (the
"Preferred Securities").

         This opinion is furnished to you pursuant to Section 3(c) of the
Purchase Agreement, dated November 6, 2003 (the "Purchase Agreement"), among the
Trust, the Company, and Dekania CDO I, Ltd. (the "Purchaser"). Capitalized terms
not otherwise defined herein have the respective meanings given to them in the
Purchase Agreement.

         In connection with this opinion, we have examined originals, or copies
certified or otherwise identified to our satisfaction, of minutes of meetings of
the Board of Directors of PXRE Corporation, a Delaware corporation ("PXRE
Corporation"); the Purchase Agreement; the Amended and Restated Trust Agreement
dated as of November 6, 2003 (the "Trust Agreement"), among the Company, as
depositor, the Property Trustee (as defined therein), the Delaware Trustee (as
defined therein), the Administrative Trustees (as defined therein), and the
Holders (as defined therein); the Junior Subordinated Indenture dated as of
November 6, 2003 (the "Indenture"), between the Company and JPMorgan Chase Bank
(the "Trustee"); the Notes; the Preferred Securities; the Guarantee Agreement
dated as of November 6, 2003 (the "Guarantee Agreement") between the Company and
JPMorgan Chase Bank as trustee for the benefit of the Holders (as defined
therein); and the Junior Subordinated Note Purchase Agreement dated as of
November 6, 2003 (the "Subscription Agreement", and together with the Purchase
Agreement, the Trust Agreement, the Indenture, the Notes, the Preferred
Securities and the Guarantee Agreement, sometimes referred to hereinafter as the
"Transaction Documents") between the Company and the Trust; and such
certificates of public officials, certificates of officers of the Company,
corporate records, documents and other certificates, opinions and instruments,
and have made such other investigations, as we have deemed relevant and
necessary as a basis for the opinions hereinafter expressed.

                                     A-I-1
<PAGE>

         For purposes of the opinions expressed herein, we have assumed the
genuineness of all signatures, the legal capacity of all natural persons
executing agreements, instruments or documents, the completeness and
authenticity of all records and documents submitted to us as originals and the
conformity with the originals of all records and documents submitted to us as
copies. The opinions are subject to the qualification that we have relied, as to
matters of fact (including determinations with respect to the question of
materiality to the Company and its subsidiaries including, without limitation,
PXRE Corporation), to the extent we deem proper, on the representations and
warranties in the Purchase Agreement, certificates of officers or other
representatives of the Company, the Trust and PXRE Corporation and certificates
of public officials.

         We have also assumed for purposes of this opinion that (i) each of the
parties to the Transaction Documents (a) is validly existing and in good
standing in the respective jurisdiction of its organization and has satisfied
all applicable governmental requirements and other laws and requirements, in
each case to the extent necessary for its execution, delivery and performance of
the respective Transaction Documents to which it is a party, (b) has the
requisite corporate, company or partnership power and authority, respectively,
to act with respect to the authorization, execution, delivery and performance of
such documents and agreements to which it is a party, and (c) has duly and
validly authorized, executed and delivered each of such documents and agreements
to which it is a party; and (ii) each of the Transaction Documents to which the
Company is a party constitutes a valid and binding agreement of the Company
under the laws of Bermuda.

         The opinions expressed below are limited to the laws of the State of
New York, the federal laws of the United States and the General Corporation Law
of the State of Delaware. The opinions expressed below in Paragraph 1 as to the
due qualification and good standing of PXRE Corporation are based solely upon
our review of certificates issued by public officials and by officers of PXRE
Corporation or the Company, and the opinions expressed below in Paragraph 1 as
to the ownership of stock are based solely upon our review of PXRE Corporation's
stock register. We express no opinion as to the securities or "Blue Sky" laws of
any jurisdiction other than the federal securities laws of the United States.
Whenever our opinion is indicated to be "known to us" or "to the best of our
knowledge", we are referring only to the actual knowledge of those of our
attorneys who have represented the Company in connection with the transactions
contemplated by the Purchase Agreement, without any independent investigation by
us of the applicable facts.

                                     A-I-2
<PAGE>

         Based upon and subject to the foregoing, we are of the opinion that:

         1. PXRE Corporation is validly existing as a corporation in good
standing under the laws of the State of Delaware, with full corporate power and
authority to own or lease its properties and conduct its business as presently
conducted in all material respects. To the best of our knowledge, all
outstanding shares of capital stock of PXRE Corporation have been duly
authorized and validly issued, and are fully paid and non-assessable and owned
of record by PXRE Reinsurance (Barbados) Ltd.

         2. Each of the Indenture and the Guarantee Agreement is a valid and
binding agreement of the Company, enforceable against the Company in accordance
with its terms, except as rights to indemnification and contribution thereunder
may be limited by applicable law or the public policy underlying such laws and
except as the enforcement thereof may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws relating to or affecting the
rights and remedies of creditors or by general equitable principles.

         3. The Notes have been delivered to the Indenture Trustee for
authentication in accordance with the Indenture. Assuming (a) the Notes are
authenticated in accordance with the terms of the Indenture and (b) the Notes
are delivered to and paid for by the Trust pursuant to the Purchase Agreement,
the Notes constitute legally valid and binding obligations of the Company,
entitled to the benefits of the Indenture and enforceable against the Company in
accordance with their terms, except as the enforcement thereof may be limited by
bankruptcy, insolvency, reorganization, moratorium or other similar laws
relating to or affecting the rights and remedies of creditors or by general
equitable principles.

         4. To the best of our knowledge, PXRE Corporation is not in breach or
violation of, or default under, with or without notice or lapse of time or both,
its Articles of Incorporation, Charter or By-Laws. The execution, delivery and
performance of the Transaction Documents and the consummation of the
transactions contemplated thereby do not and will not (i) conflict with,
constitute a material breach or violation of, or constitute a material default
under, with or without notice or lapse of time or both, any of the terms,
provisions or conditions of (A) the Articles of Incorporation, Charter or
By-Laws of PXRE Corporation, or (B) to the best of our knowledge, any material
contract, indenture, mortgage, deed of trust, loan or credit agreement, note,
lease, franchise, license or any other material agreement or instrument to which
PXRE Corporation is a party or by which it or any of its properties may be
bound, or (C) any judgment, order, decree, franchise, license, permit or
regulation of any court, arbitrator, government, or governmental agency or
instrumentality in jurisdictions covered by this opinion and known to us and
binding on PXRE Corporation which, in the case of each of (A), (B) or (C) above,
is material to the Company and its subsidiaries on a consolidated basis or (ii)
pursuant to any material contract, indenture or other material agreement or
instrument, result in the creation or imposition of any material lien, claim,
charge, encumbrance or restriction upon any property or assets of PXRE
Corporation.

                                     A-I-3
<PAGE>

         5. Assuming the accuracy of the representations and warranties and
compliance with the agreements of the Purchaser contained in the Purchase
Agreement, the Subscription Agreement, the Indenture and the Trust Agreement, as
applicable, neither registration of the Preferred Securities, the Common
Securities, the Notes and the Guarantee Agreement under the Securities Act of
1933, as amended, nor qualification of the Indenture under the Trust Indenture
Act of 1939, as amended, is required for the offer, sale and delivery of the
Preferred Securities, the Common Securities, the Notes, the Guarantee Agreement
and the Guarantee under the circumstances contemplated by the Transaction
Documents. No opinion is expressed with respect to any re-offer or resale of the
Preferred Securities by the Purchaser or any sale by the Purchaser of its
securities.

         6. The Trust is not, and, after giving effect to the offering and sale
of the Preferred Securities and the consummation of the transactions described
in the Purchase Agreement will not be, an "investment company" or entity
"controlled" by an "investment company", in each case within the meaning of
Section 3(a) of the Investment Company Act.

         7. No consent, approval, authorization or other order of, or subject to
the assumptions and qualifications set forth in paragraph 5, registration,
qualification or filing with, any New York court or U.S. federal court or other
New York or U.S. federal governmental authority or agency is required for the
consummation of the transactions contemplated by the Transaction Documents.

                  The foregoing opinions are given as of the date hereof and we
         assume no obligation to update or supplement them to reflect any facts
         or circumstances which may hereafter come to our attention or any
         changes in laws which may hereafter occur.

                  This letter is rendered at the request of the Company and is
         for the sole benefit of, and may be relied upon only by, the
         addressees.

                                                              Very truly yours,

                                     A-I-4
<PAGE>

                                                                      ANNEX A-II

November 6, 2003

                                                              Matter No: 2030271

Dekania CDO I, Ltd.
c/o Dekania Capital Management, LLC
1818 Market Street, 28th Floor
Philadelphia, PA 19106

JPMorgan Chase Bank
600 Travis, Suite 1150
Attention: Institutional Trust Services

Attn: Institutional Trust Services

Ladies and Gentlemen:

                      Re: PXRE Reinsurance (Barbados) Ltd.
                          -Issue of Fixed/Floating Rate Preferred Securities
                          --------------------------------------------------

         We have been asked to provide this legal opinion in connection with the
offer, issue and sale by PXRE Group Ltd. ("PXRE Group") and PXRE Capital Trust
VI, (the "Trust"), of US$10,000,000.00 aggregate principal amount of
Fixed/Floating Rate Preferred Securities (the "Preferred Securities"), to
Dekania CDO I, Ltd. (the "Purchaser") pursuant to the terms of a Purchase
Agreement (the "Purchase Agreement"), dated as of November 6, 2003 between the
PXRE Group and the Trust (together, the "Offerors") and the Purchaser.

         We have acted as special Barbados counsel to PXRE Reinsurance
(Barbados) Ltd. ("PXRE Barbados"), a wholly-owned subsidiary of PXRE Group, and
as such a Significant Subsidiary of PXRE Group. This legal opinion is given
pursuant to section 3(c) of the Purchase Agreement. Capitalised terms used and
not otherwise defined herein have the meanings ascribed to such terms in the
Purchase Agreement.

                                     A-II-2
<PAGE>

         In connection therewith, and in respect of the issue of the Preferred
Securities, we have examined originals or copies identified to our satisfaction
of the following documents:

         (i)         the Purchase Agreement;

         (ii)        the officer's certificate (the "Officer's Certificate"),
                     issued on behalf of PXRE Group and PXRE Barbados by duly
                     authorised officers of each of PXRE Group and PXRE Barbados
                     confirming inter alia that PXRE Group has not entered into
                     any agreement or other arrangement by which the execution,
                     delivery and performance of the Purchase Agreement and the
                     Operative Documents and the consummation of the
                     transactions contemplated by the Purchase Agreement and the
                     Operative Documents results in the creation or imposition
                     of any material lien, claim, charge, encumbrance or
                     restriction upon any property or assets of PXRE Barbados;

         (iii)       (a) the certificate and articles of incorporation as
                     amended (the "Corporate Instruments") of PXRE Barbados, (b)
                     the By-Laws (the "By-Laws"), of PXRE Barbados, (c) the
                     insurance licence issued by the Supervisor of Insurance
                     (Barbados) and the business plan, issued and adopted
                     respectively, pursuant to the Insurance Act of the laws of
                     Barbados, and filed with the Office of the Supervisor of
                     Insurance (Barbados), (the business plan together with the
                     insurance licence the "Insurance Licence"), and (d) the
                     share register (the "Share Register") of PXRE Barbados; and

         (iv)        a certificate of Good Standing issued under the hand of the
                     Registrar of Corporate Affairs (Barbados).

         In our examination of the foregoing documents, we have assumed the
genuineness of all signatures, the authenticity and completeness of all
documents submitted to us as originals, and the conformity to original documents
of all documents submitted to us as notarial, true, certified, conformed,
photostatic or telecopied copies thereof; and the completeness and accuracy of
all facts set forth in official public records and certificates and other
documents issued by public officials.

         We have also assumed, as a basis for the opinions hereafter expressed,
that neither the Offerors nor the Purchaser will sell or otherwise distribute
any Preferred Securities in Barbados.

         In rendering the opinions set forth herein, we have relied (without
independent check or verification) as to certain matters of fact solely upon the
Officer's Certificate.

         We are qualified to practise law only in Barbados and have made no
investigation of laws of any jurisdiction other than the laws of Barbados. We
express no opinion as to the laws of any jurisdiction other than Barbados, and
the opinions hereinafter expressed are limited to the laws of Barbados in effect
on the date hereof.

                                     A-II-3
<PAGE>

         Based upon the foregoing and subject to the limitations, qualifications
and assumptions set forth herein, it is our opinion that:-

1.          PXRE Barbados is a body corporate duly organised, validly existing
            and in good standing under the laws of Barbados and has full
            corporate power and authority necessary to own or lease its
            properties and to conduct its business as now being conducted in all
            material respects.

2.          All issued and outstanding shares in the capital of PXRE Barbados
            have been duly and validly authorised and issued, are fully paid and
            non-assessable and are owned of record and beneficially, directly or
            indirectly by PXRE Group.

3.          To the best of our knowledge, PXRE Barbados is not in breach or
            violation of, or default under (with or without notice or the lapse
            of time, or both) its Corporate Instruments, By-Laws or Insurance
            Licence.

4.          The execution, delivery and performance of the Purchase Agreement
            and the Operative Documents by PXRE Group, and the consummation of
            the transactions contemplated by the Purchase Agreement and the
            Operative Documents do not and will not:

            (a)     result in the creation or imposition of any material lien,
                    claim, charge, encumbrance or restriction upon any property
                    or assets of PXRE Barbados;

            (b)     conflict with, constitute a material breach or violation of,
                    or constitute a material default under (with or without
                    notice or lapse of time or both), any of the terms
                    provisions or conditions of its Corporate Instruments,
                    By-Laws or Insurance Licence;

            (c)     to the best of our knowledge, conflict with, constitute a
                    material breach or violation of, or constitute a material
                    default under (with or without notice or lapse of time or
                    both), any of the terms provisions or conditions of any
                    material contract, indenture, mortgage, deed of trust, loan
                    or credit agreement, note, lease, franchise, license or any
                    other agreement or instrument to which PXRE Barbados is a
                    party or by which it or any of its properties may be bound
                    and which is material to PXRE Barbados; or

            (d)     to the best of our knowledge, conflict with, constitute a
                    material breach or violation of, or constitute a material
                    default under (with or without notice or lapse of time or
                    both), any order, decree, judgement, franchise, license,
                    permit, rule or regulation of any court, arbitrator,
                    government or governmental agency or instrumentality, in
                    Barbados or elsewhere as known to us having jurisdiction
                    over PXRE Barbados or any of its properties and which is
                    material to PXRE Barbados.

                                     A-II-4
<PAGE>

5.          To the best of our knowledge, (a) no action, suit or proceeding at
            law or in equity is pending or threatened to which PXRE Barbados may
            be a party, and (b) no action, suit or proceeding is pending or
            threatened against or affecting PXRE Barbados or any of its
            properties, before or by any court or governmental official,
            commission, board or other administrative agency, authority or body,
            or any arbitrator, wherein an unfavourable decision, ruling or
            finding could reasonably be expected to have a material adverse
            effect on the consummation of the transactions contemplated by the
            Operative Documents or the issuance and sale of the Preferred
            Securities as contemplated therein or the condition (financial or
            otherwise), earnings, affairs, business, or results of operations of
            PXRE Barbados.

         For the purpose of our opinion, the term "to the best of our knowledge"
means that, except for such investigations or inquiries of proper executive
officers of the Company, and in the public registers in Barbados, we have not
made any further investigations or inquiries, but we have not in the course of
acting for the Company, acquired any knowledge or received any information to
cause us to believe that the statements qualified by that expression are not
correct.

         This opinion is intended solely for the benefit of the persons to whom
it is addressed, in connection with certain aspects of the transactions
contemplated by the Purchase Agreement and the Operative Documents. This opinion
may be relied upon, quoted and referred to by Morgan, Lewis & Bockius LLP, for
the purpose of their rendering legal opinions in connection with the Purchase
Agreement and the Operative Documents and the transactions contemplated thereby.
Subject thereto, this opinion is not to be transmitted to any other person, nor
is it to be relied upon by any of the persons to whom it is addressed or by any
other person for any other purpose, or quoted or referred to in any public
document or filed with any governmental agency or other person without prior
written consent.

                                            Yours very truly,
                                            Chancery Chambers

                                        per:

ACF:est

                                     A-II-5
<PAGE>

                                                                     ANNEX A-III

November 6, 2003

To the Persons listed in the Schedule
annexed hereto

Dear Sirs

PXRE Group Ltd. (the "Company")

We have acted as special legal counsel in Bermuda to the Company in connection
with a Purchase Agreement dated November 6, 2003 (the "Purchase Agreement")
between the Company, PXRE Capital Trust VI (the "Trust") and Dekania CDO I, Ltd.

For the purposes of giving this opinion, we have examined the following
documents:

(i)      an electronic copy (with facsimile execution signature pages) of a
         trust agreement dated as of November 6, 2003 by and among JPMorgan
         Chase Bank, Chase Manhattan Bank USA, National Association and the
         Company;

(ii)     an electronic copy (with facsimile execution signature pages) of an
         amended and restated trust agreement dated as of November 6, 2003 by
         and among JPMorgan Chase Bank, Chase Manhattan Bank USA, National
         Association, the Company and Messrs. John Modin, Bruce Byrnes and Jeff
         Jeffreys, each as an Administrative Trustee ("Trust Agreement");

(iii)    an electronic copy (with facsimile execution signature pages) of the
         Purchase Agreement;

(iv)     an electronic copy (with facsimile execution signature pages) of an
         indenture dated as of November 6, 2003 by and between the Company and
         JPMorgan Chase Bank, relating to the Floating Rate Junior Subordinated
         Deferrable Interest Notes ("Indenture");

(v)      an electronic copy of the form of the Floating Rate Junior Subordinated
         Deferrable Interest Note;

(vi)     an electronic copy (with facsimile execution signature pages) of the
         junior subordinated note purchase agreement dated as of November 6,
         2003, (the "Note Purchase Agreement") by and among the Company and the
         Trust relating to the Junior Subordinated Notes due 2033 (the "Junior
         Subordinated Notes");

(vii)    an electronic copy (with facsimile execution signature pages) of the
         common securities subscription agreement dated as of November 6, 2003,
         between the Trust and the Company relating to the Trust's common
         securities (the "Common Securities Subscription Agreement"); and

                                    A-III-1
<PAGE>
(viii)   an electronic copy (with facsimile execution signature pages) dated as
         of November 6, 2003, of a guarantee agreement by and among the Company
         and JPMorgan Chase Bank ("Guarantee Agreement").

The documents listed in items (i) through (viii) above are herein sometimes
collectively referred to as the "Documents", the documents listed in items (i)
and (ii) above are herein sometimes collectively referred to as the "Delaware
Law Documents" and the documents listed in items (iii) through (viii) above are
herein sometimes collectively referred to as the "New York Law Documents" (which
terms do not include any other instrument or agreement whether or not
specifically referred to therein or attached as an exhibit or schedule thereto).

We have also reviewed the memorandum of association and the bye-laws of the
Company, each certified by the Secretary of the Company on November 6, 2003,
resolutions adopted by the unanimous written consent of the board of directors
of the Company effective May 28 & 29, 2003, and resolutions adopted by the
unanimous written consent of the Pricing Committee of the Board of Directors of
the Company effective May 28 & 29, 2003, (the "Minutes"), and such other
documents and made such enquiries as to questions of law as we have deemed
necessary in order to render the opinion set forth below.

We have assumed (a) the genuineness and authenticity of all signatures and the
conformity to the originals of all copies (whether or not certified) examined by
us and the authenticity and completeness of the originals from which such copies
were taken, (b) that where a document has been examined by us in draft form, it
will be or has been executed in the form of that draft, and where a number of
drafts of a document have been examined by us all changes thereto have been
marked or otherwise drawn to our attention, (c) the capacity, power and
authority of each of the parties to the Documents, other than the Company, to
enter into and perform its respective obligations under the Documents, (d) the
due execution and delivery of the Documents by each of the parties thereto,
other than the Company, (e) the accuracy and completeness of all factual
representations made in the Documents and other documents reviewed by us, (f)
that the resolutions contained in the Minutes remain in full force and effect
and have not been rescinded or amended, (g) that the Company is entering into
the Documents pursuant to its business of a holding company, (h) that there is
no provision of the law of any jurisdiction, other than Bermuda, which would
have any implication in relation to the opinions expressed herein, (i) the
validity and binding effect under the laws of the State of New York in the
United States of America (the "New York Laws") of the New York Law Documents
which are expressed to be governed by such New York Laws in accordance with
their respective terms, (j) the validity and binding effect under the laws of
the State of Delaware in the United States of America (the "Delaware Laws") of
the Delaware Law Documents which are expressed to be governed by such Delaware
Laws in accordance with their respective terms, (k) the validity and binding
effect under the New York Laws of the submission by the Company pursuant to the
Purchase Agreement, Common Securities Subscription Agreement, Note Purchase
Agreement, Indenture and Guarantee to the non-exclusive jurisdiction of the
Courts of the State of New York or of the United States of America for the
Southern District of New York, in each case sitting in the Borough of Manhattan,
The City of New York in the United States of America (the "Foreign Courts"), (l)
that none of the parties to the Documents has carried on or will carry on
activities, other than the performance of its obligations under the Documents,
which would constitute the carrying on of investment business in or from within
Bermuda and that none of the parties to the Documents, other than the Company,
will perform its obligations under the Documents in or from within Bermuda.

                                    A-III-2
<PAGE>

The obligations of the Company under the Documents (a) will be subject to the
laws from time to time in effect relating to bankruptcy, insolvency,
liquidation, possessory liens, rights of set off, reorganisation, amalgamation,
moratorium or any other laws or legal procedures, whether of a similar nature or
otherwise, generally affecting the rights of creditors, (b) will be subject to
statutory limitation of the time within which proceedings may be brought, (c)
will be subject to general principles of equity and, as such, specific
performance and injunctive relief, being equitable remedies, may not be
available, (d) may not be given effect to by a Bermuda court, whether or not it
was applying the New York Laws or the Delaware Laws, if and to the extent they
constitute the payment of an amount which is in the nature of a penalty and not
in the nature of liquidated damages. Notwithstanding any contractual submission
to the jurisdiction of specific courts, a Bermuda court has inherent discretion
to stay or allow proceedings in the Bermuda courts.

We express no opinion as to the enforceability of any provision of the Documents
which provides for the payment of a specified rate of interest on the amount of
a judgment after the date of judgment or which purports to fetter the statutory
powers of the Company.

We have made no investigation of and express no opinion in relation to the laws
of any jurisdiction other than Bermuda. This opinion is to be governed by and
construed in accordance with the laws of Bermuda and is limited to and is given
on the basis of the current law and practice in Bermuda. This opinion is issued
solely for your benefit and is not to be relied upon by any other person, firm
or entity or in respect of any other matter.

On the basis of and subject to the foregoing, we are of the opinion that:

1.       The Company is duly incorporated and validly existing under the laws of
         Bermuda in good standing (meaning solely that it has not failed to make
         any filing with any Bermuda government authority, or to pay any Bermuda
         government fee or tax, which would make it liable to be struck off the
         Register of Companies and thereby cease to exist under the laws of
         Bermuda).

2.       The Company has the necessary corporate power and authority to execute
         and deliver, and perform its obligations under the Documents. The
         execution and delivery of the Documents by the Company and the
         performance by the Company of its obligations thereunder and the
         consummation by the Company of the transactions contemplated thereby
         will not violate the memorandum of association or bye-laws of the
         Company nor any applicable law, regulation, order or decree in Bermuda.

                                    A-III-3
<PAGE>

3.       The Documents have been duly authorised, executed and delivered by or
         on behalf of the Company, and constitute the valid and binding
         obligations of the Company in accordance with the terms thereof.

4.       No order, consent, approval, licence, authorisation, filing
         registration or qualification with, or validation of, or exemption by
         any government or public body or authority of Bermuda is required by
         any law or regulation of Bermuda to authorise or is required by any law
         or regulation of Bermuda in connection with the execution, delivery,
         performance and enforcement of the Documents and the consummation of
         the transactions contemplated thereby, except such as have been duly
         obtained in accordance with Bermuda law.

5.       The choice of the New York Laws as the governing law of the New York
         Law Documents, and the choice of the Delaware Laws as the governing law
         of the Delaware Law Documents, are valid choices of law under the laws
         of Bermuda and would be recognised and given effect to in any action
         brought before a court of competent jurisdiction in Bermuda, except for
         those laws (i) which such court considers to be procedural in nature,
         (ii) which are revenue or penal laws or (iii) the application of which
         would be inconsistent with public policy, as such term is interpreted
         under the laws of Bermuda.

6.       The courts of Bermuda would recognise as a valid judgment, any final
         and conclusive judgment in personam obtained in the Foreign Courts in
         respect of any suit, action or proceeding against the Company based
         upon or arising under any Documents under which a sum of money is
         payable (other than a sum of money payable in respect of multiple
         damages, taxes or other charges of a like nature or in respect of a
         fine or other penalty) and would give a judgment based thereon without
         (i) a re-examination or review of the merits of the cause of action in
         which the original judgment was given or (ii) a re-examination of the
         matters adjudicated upon or (iii) payment of any stamp registration or
         similar tax or duty (other than de minimis filing and other court
         fees), provided that (a) such courts had proper jurisdiction over the
         parties subject to such judgment, (b) such courts did not contravene
         the rules of natural justice of Bermuda, (c) such judgment was not
         obtained by fraud, (d) the enforcement of the judgment would not be
         contrary to the public policy of Bermuda, (e) no new admissible
         evidence relevant to the action is submitted prior to the rendering of
         the judgment by the courts of Bermuda and (f) there is due compliance
         with the correct procedures under the laws of Bermuda.

7.       There is no income or other tax of Bermuda imposed by withholding or
         otherwise on any payment to be made to or by the Company pursuant to
         the Documents.

8.       No stamp duty or similar tax or duty is payable under any law or
         regulation of or in Bermuda in connection with (i) the creation,
         issuance, delivery and performance of the Junior Subordinated Notes,
         the Common Securities or the Guarantee Agreement, the transfer of the
         Junior Subordinated Notes or the Common Securities or (ii) the
         execution, delivery and performance by the Company or the Trust of any
         of the Documents.

                                    A-III-4
<PAGE>

9.       The Documents will not be subject to ad valorem stamp duty in Bermuda
         and no registration, documentary, recording, transfer or other tax, fee
         or charge is payable in Bermuda in connection with the execution,
         delivery, filing, registration or performance of the Documents or any
         payments of principal, premium (if any), interest and other amounts
         payable in respect of the Junior Subordinated Notes or the Common
         Securities.

10.      The Trust will not be subject to, or otherwise required to pay, taxes,
         duties, assessments or other governmental charges of any type imposed
         or levied by or on behalf of Bermuda or any taxing authority thereof by
         virtue only of the execution, delivery, performance and/or enforcement
         of the Documents by the Trust.

11.      Based solely upon a search of the Cause Book of the Supreme Court of
         Bermuda conducted at 10:50 am on November 5, 2003 (which would not
         reveal details of proceedings which have been filed but not actually
         entered in the Cause Book at the time of our search), there are no
         judgments against the Company, nor any legal or governmental
         proceedings pending in Bermuda to which the Company is subject.

12.      Based solely on a search of the public records in respect of the
         Company maintained at the offices of the Registrar of Companies at
         11:30 am on November 5, 2003 (which would not reveal details of matters
         which have not been lodged for registration or have been lodged for
         registration but not actually registered at the time of our search) and
         a search of the Cause Book of the Supreme Court of Bermuda conducted at
         10:50 am on November 5, 2003 (which would not reveal details of
         proceedings which have been filed but not actually entered in the Cause
         Book at the time of our search), no steps have been, or are being,
         taken in Bermuda for the appointment of a receiver or liquidator to, or
         for the winding-up, dissolution, reconstruction or reorganisation of,
         the Company, though it should be noted that the public files maintained
         by the Registrar of Companies do not reveal whether a winding-up
         petition or application to the Court for the appointment of a receiver
         has been presented and entries in the Cause Book may not specify the
         nature of the relevant proceedings.

Yours faithfully

CONYERS DILL & PEARMAN

                                    A-III-5
<PAGE>

                                    SCHEDULE

PXRE Group Ltd.
Swan Building
26 Victoria Street
Hamilton
Bermuda

Dekania CDO I, Ltd.
c/o Dekania Capital Management, LLC
1818 Market Street, 28th Floor
Philadelphia, PA 19106
U.S.A.

JPMorgan Chase Bank
600 Travis, Suite 1150
Houston, Texas 77002
U.S.A.
Attention: Institutional Trust Services

                                    A-III-6
<PAGE>

                                                                      ANNEX A-IV

                              OFFICER'S CERTIFICATE
                                       OF
                                 PXRE GROUP LTD.

         This certificate is being delivered to Dekania CDO I, Ltd. (the
"Purchaser") pursuant to Section 3(c) of the Purchase Agreement referred to
below in connection with the issuance and sale of the Fixed/Floating Rate Junior
Subordinated Deferrable Notes Due 2033, Series E (the "Debentures") by PXRE
Group Ltd. (the "Company") to the PXRE Capital Trust VI (the "Trust") and the
issuance and sale by the Trust of the preferred securities (the "Preferred
Securities") and the common securities of the Trust (the "Common Securities") to
the Purchaser and the Company, respectively.

         I, John Modin, Senior Vice President and Chief Financial Officer of the
Company, a Bermuda company, do hereby certify to the Purchaser as to the
following information:

         1.       Each of PXRE Reinsurance Ltd., a Bermuda company ("PXRE
                  Bermuda") and PXRE Reinsurance Company, a Connecticut
                  corporation ("PXRE Reinsurance Company"), is validly existing
                  as a corporation in good standing under the laws of the State
                  of Connecticut and the laws of Bermuda respectively, with full
                  corporate power and authority to own or lease its properties
                  and conduct its business as presently conducted in all
                  material respects. To the best of my knowledge, all
                  outstanding shares of capital stock of PXRE Reinsurance
                  Company have been duly authorized and validly issued, and are
                  fully paid and non-assessable and owned of record by PXRE
                  Corporation, a Delaware corporation, and all outstanding share
                  capital of PXRE Bermuda have been duly authorized and validly
                  issued, and are fully paid and non-assessable and owned of
                  record by the Company.

         2.       Neither the Company nor any of its "Affiliates" (as defined in
                  Rule 501(b) of Regulation D under the Securities Act
                  ("Regulation D")) has directly or indirectly, made offers or
                  sales of any security, or solicited offers to buy any
                  security, under circumstances that would require the
                  registration of any of the Notes, the Preferred Securities or
                  the Common Securities being issued pursuant to this
                  transaction under the Securities Act of 1933, as amended,
                  engaged in any form of general solicitation or general
                  advertising (within the meaning of Regulation D) in connection
                  with any offer or sale of any of the Securities, or engaged,
                  nor will engage, in any "directed selling efforts" within the
                  meaning of Regulation S under the Securities Act with respect
                  to the Securities.

         3.       To the best of my knowledge, none of the Company, the Trust,
                  PXRE Reinsurance Company and PXRE Bermuda is in breach or
                  violation of, or default under, with or without notice or
                  lapse of time or both, its Articles of Incorporation, Charter,
                  By-Laws or the Trust Agreement.

                                     A-IV-1
<PAGE>

         4.       The execution, delivery and performance of the Purchase
                  Agreement dated November 6, 2003 (the "Purchase Agreement")
                  and the Operative Documents and the consummation of the
                  transactions contemplated by the Purchase Agreement and the
                  Operative Documents do not and will not (i) result in the
                  creation or imposition of any material lien, claim, charge,
                  encumbrance or restriction upon any property or assets of the
                  Company, PXRE Corporation, PXRE Reinsurance Company or PXRE
                  Bermuda, or (ii) conflict with, constitute a material breach
                  or violation of, or constitute a material default under, with
                  or without notice or lapse of time or both, any of the terms,
                  provisions or conditions of, (A) to the best of our knowledge,
                  any material contract, indenture, mortgage, deed of trust,
                  loan or credit agreement, note, lease, franchise, license or
                  other agreement or instrument to which the Company, PXRE
                  Reinsurance Company or PXRE Bermuda is a party or by which any
                  of their respective properties may be bound or (B) any
                  judgment, order, decree, franchise, license, permit, rule or
                  regulation of any court, arbitrator, government, or
                  governmental agency or instrumentality known to me and binding
                  on the Company, PXRE Reinsurance Company or PXRE Bermuda or
                  any of their respective properties which, in the case of each
                  of (i) or (ii) above, is material to the Company and its
                  Significant Subsidiaries on a consolidated basis.

         5.       Except as disclosed in Schedule 1 hereto, to the best of my
                  knowledge, (i) no action, suit or proceeding at law or in
                  equity is pending or threatened to which the Company, the
                  Trust or its Significant Subsidiaries are or may be a party,
                  and (ii) no action, suit or proceeding is pending or
                  threatened against or affecting the Company, the Trust or its
                  Significant Subsidiaries or any of their properties, before or
                  by any court or governmental official, commission, board or
                  other administrative agency, authority or body, or any
                  arbitrator, in the case of each of (i) or (ii) wherein an
                  unfavorable decision, ruling or finding could reasonably be
                  expected to have a material adverse effect on the consummation
                  of the transactions contemplated by the Operative Documents or
                  the issuance and sale of the Common Securities or the
                  Preferred Securities as contemplated therein or the condition
                  (financial or otherwise), earnings, affairs, business, or
                  results of operations of the Company and its Significant
                  Subsidiaries on a consolidated basis.

         6.       The issuance of the Preferred Securities and the Common
                  Securities is not subject to any contractual preemptive rights
                  known to me.

         7.       To the best of my knowledge, no consent, approval,
                  authorization or order of any court or governmental authority
                  is required for the issue and sale of the Common Securities,
                  the Preferred Securities or the Notes, the purchase by the
                  Trust of the Notes, the execution and delivery of and
                  compliance with the Operative Documents by the Company or the
                  Trust or the consummation of the transactions contemplated in
                  the Operative Documents, except such approvals as have been
                  obtained.

         8.       The Company's significant insurance subsidiaries are in
                  compliance with all capital requirements imposed by applicable
                  Regulatory Agencies.

         The above representations are accurate as of the date hereof. The
undersigned possesses the authority to make the representations set forth in
this letter on behalf of the Company.

         Capitalized terms not otherwise defined herein have the respective
meanings given to them in the Purchase Agreement.

                                     A-IV-2
<PAGE>

         IN WITNESS WHEREOF, I have signed this Certificate, as of the November
6, 2003.

                                        PXRE GROUP LTD.

                                        By:______________________
                                        Name: John Modin
                                        Title:  Senior Vice President
                                                and Chief Financial Officer

                                     A-IV-3
<PAGE>

                                   Schedule 1

         In April 2000, PXRE Reinsurance Company entered into an Aggregate
Excess of Loss Retrocessional Reinsurance Agreement (the "Agreement") with a
U.S. based cedent. In the Agreement, PXRE Reinsurance Company reinsured a
portfolio of treaties (the "Protected Portfolio") underwritten by a former
business unit of the cedent which had been divested. Pursuant to this Agreement,
PXRE Reinsurance Company agreed to indemnify the cedent for losses in excess of
a 75% paid loss ratio on the underlying Protected Portfolio up to a 100% paid
loss ratio, subject to an aggregate limit of liability of $50 million. The
latest loss reports related to the Agreement provided by the cedent forecast an
ultimate net loss ratio in excess of 100%, which could result in a full limit
loss to PXRE Group Ltd.

         In June 2003, PXRE Reinsurance Company performed an audit of the
Protected Portfolio reinsured under the Agreement. As a result of this audit,
management identified problems and believes that the cedent may have breached
its contractual obligations and fiduciary duties under the Agreement. PXRE
Reinsurance Company therefore filed suit against the cedent on July 24, 2003 in
a United States District Court seeking rescission of the Agreement and/or
compensatory and punitive damages.

         Although the ultimate outcome of the litigation cannot presently be
determined, management believes that PXRE Reinsurance Company's claims are
meritorious and intends to vigorously prosecute its suit. As of June 30, 2003,
PXRE Reinsurance Company recorded $34 million of loss reserves related to the
Agreement. If PXRE Reinsurance Company's lawsuit is unsuccessful, it could
potentially incur additional losses under the Agreement of up to $10.4 million
on an after-tax basis.

                                     A-IV-4
<PAGE>

                                                                         ANNEX B

                  Pursuant to Section 3(d) of the Purchase Agreement, Mayer,
Brown, Rowe & Maw LLP, special tax counsel for the Purchaser, shall deliver an
opinion to the effect that:

(i)      the Trust will be classified for United States federal income tax
         purposes as a grantor trust and not as an association or a publicly
         traded partnership taxable as a corporation; and

(ii)     for United States federal income tax purposes, the Junior Subordinated
         Notes will constitute indebtedness of the Company.

         In rendering such opinions, such counsel may (A) state that its opinion
is limited to the federal laws of the United States and (B) rely as to matters
of fact, to the extent deemed proper, on certificates of responsible officers of
the Company and public officials.

                                      B-1
<PAGE>

                                                                         ANNEX C

                  Pursuant to Section 3(e) of the Purchase Agreement, Richards,
Layton & Finger, P.A., special Delaware counsel for the Purchaser and the
Delaware Trustee, shall deliver an opinion to the effect that:

                  (i) the Trust has been duly created and is validly existing in
         good standing as a statutory trust under the Delaware Statutory Trust
         Act, and all filings required under the laws of the State of Delaware
         with respect to the creation and valid existence of the Trust as a
         statutory trust have been made;

                  (ii) under the Delaware Statutory Trust Act and the Trust
         Agreement, the Trust has the trust power and authority (A) to own
         property and conduct its business, all as described in the Trust
         Agreement, (B) to execute and deliver, and to perform its obligations
         under, each of the Purchase Agreement, the Common Securities
         Subscription Agreement, the Junior Subordinated Note Purchase Agreement
         and the Preferred Securities and the Common Securities and (C) to
         purchase and hold the Junior Subordinated Notes;

                  (iii) under the Delaware Statutory Trust Act, the certificate
         attached to the Trust Agreement as Exhibit C is an appropriate form of
         certificate to evidence ownership of the Preferred Securities; the
         Preferred Securities have been duly authorized by the Trust Agreement
         and, when issued and delivered against payment of the consideration as
         set forth in the Purchase Agreement, the Preferred Securities will be
         validly issued and (subject to the qualifications set forth in this
         paragraph) fully paid and nonassessable and will represent undivided
         beneficial interests in the assets of the Trust; the holders of the
         Preferred Securities will be entitled to the benefits of the Trust
         Agreement and, as beneficial owners of the Trust, will be entitled to
         the same limitation of personal liability extended to stockholders of
         private corporations for profit organized under the General Corporation
         Law of the State of Delaware; and such counsel may note that the
         holders of the Preferred Securities may be obligated, pursuant to the
         Trust Agreement, to (A) provide indemnity and/or security in connection
         with and pay taxes or governmental charges arising from transfers or
         exchanges of Preferred Securities certificates and the issuance of
         replacement Preferred Securities certificates and (B) provide security
         or indemnity in connection with requests of or directions to the
         Property Trustee to exercise its rights and remedies under the Trust
         Agreement;

                  (iv) the Common Securities have been duly authorized by the
         Trust Agreement and, when issued and delivered by the Trust to the
         Company against payment therefor as described in the Trust Agreement
         and the Common Securities Subscription Agreement, will be validly
         issued and fully paid and will represent undivided beneficial interests
         in the assets of the Trust entitled to the benefits of the Trust
         Agreement;

                  (v) under the Delaware Statutory Trust Act and the Trust
         Agreement, the issuance of the Preferred Securities and the Common
         Securities is not subject to preemptive or other similar rights;

                                       C-1
<PAGE>
                  (vi) under the Delaware Statutory Trust Act and the Trust
         Agreement, the execution and delivery by the Trust of the Purchase
         Agreement, the Common Securities Subscription Agreement and the Junior
         Subordinated Note Purchase Agreement, and the performance by the Trust
         of its obligations thereunder, have been duly authorized by all
         necessary trust action on the part of the Trust;

                  (vii) the Trust Agreement constitutes a legal, valid and
         binding obligation of the Company and the Trustees, and is enforceable
         against the Company and the Trustees, in accordance with its terms
         subject, as to enforcement, to the effect upon the Trust Agreement of
         (i) bankruptcy, insolvency, moratorium, receivership, reorganization,
         liquidation, fraudulent conveyance or transfer and other similar laws
         relating to or affecting the rights and remedies of creditors
         generally, (ii) principles of equity, including applicable law relating
         to fiduciary duties (regardless of whether considered and applied in a
         proceeding in equity or at law), and (iii) the effect of applicable
         public policy on the enforceability of provisions relating to
         indemnification or contribution;

                  (viii) the issuance and sale by the Trust of the Preferred
         Securities and the Common Securities, the purchase by the Trust of the
         Junior Subordinated Notes, the execution, delivery and performance by
         the Trust of the Purchase Agreement, the Common Securities Subscription
         Agreement and the Junior Subordinated Note Purchase Agreement, the
         consummation by the Trust of the transactions contemplated by the
         Purchase Agreement and compliance by the Trust with its obligations
         thereunder do not violate (i) any of the provisions of the Certificate
         of Trust or the Amended and Restated Trust Agreement or (ii) any
         applicable Delaware law, rule or regulation;

                  (ix) no filing with, or authorization, approval, consent,
         license, order, registration, qualification or decree of, any Delaware
         court or Delaware governmental authority or Delaware agency is
         necessary or required solely in connection with the issuance and sale
         by the Trust of the Common Securities or the Preferred Securities, the
         purchase by the Trust of the Junior Subordinated Notes, the execution,
         delivery and performance by the Trust of the Purchase Agreement, the
         Common Securities Subscription Agreement and the Junior Subordinated
         Note Purchase Agreement, the consummation by the Trust of the
         transactions contemplated by the Purchase Agreement and compliance by
         the Trust with its obligations thereunder; and

                  (x) the holders of the Preferred Securities (other than those
         holders who reside or are domiciled in the State of Delaware) will have
         no liability for income taxes imposed by the State of Delaware solely
         as a result of their participation in the Trust and the Trust will not
         be liable for any income tax imposed by the State of Delaware.

         In rendering such opinions, such counsel may (A) state that its opinion
is limited to the laws of the State of Delaware and (B) rely as to matters of
fact, to the extent deemed proper, on certificates of responsible officers of
the Company and public officials.

                                      C-2
<PAGE>

                                                                         ANNEX D

         Pursuant to Section 3(f) of the Purchase Agreement, Locke Liddell &
Sapp LLP, special counsel for the Guarantee Trustee, the Property Trustee and
the Indenture Trustee, shall deliver an opinion to the effect that:

                  (i) JPMorgan Chase Bank is a New York banking corporation with
         trust powers duly organized and validly existing in good standing under
         the laws of the State of New York with all necessary corporate power
         and authority to execute, deliver and perform its obligations under the
         terms of the Guarantee Agreement, the Trust Agreement and the
         Indenture;

                  (ii) the execution, delivery and performance by JPMorgan Chase
         Bank of the Guarantee Agreement, the Trust Agreement and the Indenture
         have been duly authorized by all necessary corporate action on the part
         of JPMorgan Chase Bank, each of the Guarantee Agreement, the Trust
         Agreement and the Indenture has been duly executed and delivered by
         JPMorgan Chase Bank, and each of the Guarantee Agreement and the
         Indenture constitutes the legal, valid and binding obligation of
         JPMorgan Chase Bank enforceable against JPMorgan Chase Bank in
         accordance with its terms, subject to applicable bankruptcy, insolvency
         and similar laws affecting creditors' rights generally and to general
         principles of equity;

                  (iii) the execution, delivery and performance of the Guarantee
         Agreement, the Trust Agreement and the Indenture by JPMorgan Chase Bank
         do not conflict with or constitute a breach of (A) the restated
         organization certificate or by-laws of JPMorgan Chase Bank or (B) any
         law or regulation of the United States of America or the State of New
         York governing the banking or trust powers of JPMorgan Chase Bank;

                  (iv) no consent, approval or authorization of, or registration
         with or notice to, any governmental authority or agency of the United
         States of America governing the banking or trust powers of JPMorgan
         Chase Bank is required for the execution, delivery or performance by it
         of the Guarantee Agreement, the Trust Agreement or the Indenture;

                  (v) the Junior Subordinated Notes have been duly authenticated
         and delivered by JPMorgan Chase Bank; and

                  (vi) The Preferred Securities have been duly authenticated and
         delivered by JPMorgan Chase Bank.

         In rendering such opinions, such counsel may (A) state that its opinion
is limited to the laws of the State of New York and the federal laws of the
United States and (B) rely as to matters of fact, to the extent deemed proper,
on certificates of responsible officers of JPMorgan Chase Bank, the Company and
public officials.

                                      D-1
<PAGE>

                                                                         ANNEX E

         Pursuant to Section 3(g) of the Purchase Agreement, Richards, Layton &
Finger, P.A., counsel for the Purchaser and the Delaware Trustee, shall deliver
an opinion to the effect that:

                  (i) Chase Manhattan Bank USA, National Association is duly
         formed and validly existing as a national banking association under the
         federal laws of the United States of America with trust powers and with
         its principal place of business in the State of Delaware;

                  (ii) Chase Manhattan Bank USA, National Association has the
         corporate power and authority to execute, deliver and perform its
         obligations under, and has taken all necessary corporate action to
         authorize the execution, delivery and performance of, the Trust
         Agreement and to consummate the transactions contemplated thereby;

                  (iii) The Trust Agreement has been duly authorized, executed
         and delivered by Chase Manhattan Bank USA, National Association and
         constitutes a legal, valid and binding obligation of Chase Manhattan
         Bank USA, National Association, and is enforceable against Chase
         Manhattan Bank USA, National Association, in accordance with its terms
         subject as to enforcement, to the effect upon the Trust Agreement of
         (i) applicable bankruptcy, insolvency, reorganization, moratorium,
         receivership, fraudulent conveyance or transfer and similar laws
         relating to or affecting the rights and remedies of creditors
         generally, (ii) principles of equity, including applicable law relating
         to fiduciary duties (regardless of whether considered and applied in a
         proceeding in equity or at law), and (iii) the effect of applicable
         public policy on the enforceability of provisions relating to
         indemnification or contribution;

                  (iv) The execution, delivery and performance by Chase
         Manhattan Bank USA, National Association of the Trust Agreement do not
         conflict with or result in a violation of (A) articles of association
         or by-laws of Chase Manhattan Bank USA, National Association or (B) any
         law or regulation of the State of Delaware or the United States of
         America governing the banking or trust powers of Chase Manhattan Bank
         USA, National Association or, to our knowledge, without independent
         investigation, of any indenture, mortgage, bank credit agreement, note
         or bond purchase agreement, long-term lease, license or other agreement
         or instrument to which Chase Manhattan Bank USA, National Association
         is a party or by which it is bound or, to our knowledge, without
         independent investigation, of any judgment or order applicable to Chase
         Manhattan Bank USA, National Association; and

                  (v) No approval, authorization or other action by, or filing
         with, any governmental authority of the State of Delaware or the United
         States of America governing the banking and trust powers of Chase
         Manhattan Bank USA, National Association is required in connection with
         the execution and delivery by Chase Manhattan Bank USA, National
         Association of the Trust Agreement or the performance by Chase
         Manhattan Bank USA, National Association of its obligations thereunder,
         except for the filing of the Certificate of Trust with the Secretary of
         State of the State of Delaware, which Certificate of Trust has been
         filed with the Secretary of State of the State of Delaware.

                                      E-1
<PAGE>

         In rendering such opinions, such counsel may (A) state that its opinion
is limited to the laws of the State of Delaware and the federal laws of the
United States and (B) rely as to matters of fact, to the extent deemed proper,
on certificates of responsible officers of the Company and public officials.

                                      E-2
<PAGE>

                                                                         ANNEX F

                         Officer's Financial Certificate

         The undersigned, the [Chairman/Vice Chairman/Chief Executive
Officer/President/ Vice President/Chief Financial Officer/Treasurer/Assistant
Treasurer], respectively, each hereby certifies, pursuant to Section 6(h) of the
Purchase Agreement, dated as of November 6, 2003, among PXRE Group Ltd. (the
"Company"), PXRE Capital Trust VI (the "Trust") and Dekania CDO I, Ltd., that,
as of [date], [20__], the Company had the following ratios and balances:

[For each Subsidiary Insurance Company (as defined below) provide:]

[INSURANCE COMPANY]
As of [Quarterly/Annual Financial Dates], 2003

NAIC Risk Based Capital Ratio (authorized control level)                _____%
Total Policyholders' Surplus                                          $_____
Consolidated Debt to Total Policyholders' Surplus                       _____%
Total Assets                                                          $_____
NAIC Class 1 & 2 Rated Investments to
  Total Fixed Income Investments                                        _____%
NAIC Class 1 & 2 Rated Investments to Total Investments                 _____%
Return on Policyholders' Surplus                                        _____%
[For Property & Casualty Companies also provide:]
[Expense Ratio]                                                         _____%
Loss and LAE Ratio                                                      _____%
Combined Ratio                                                          _____%
Net Premiums Written (annualized) to Policyholders' Surplus             _____%]

* A table describing the quarterly report calculation procedures is
provided on page __

The following is a complete list as of [Quarterly/Annual Financial Date] of the
Company's insurance subsidiaries for which this certificate is required to be
delivered pursuant to the Operative Documents** (the "Subsidiary Insurance
Companies"):

                    [List of Subsidiary Insurance Companies]

                                      F-1
<PAGE>

[FOR FISCAL YEAR END: Attached hereto are the audited consolidated financial
statements (including the balance sheet, income statement and statement of cash
flows, and notes thereto, together with the report of the independent
accountants thereon) of the Company and its consolidated subsidiaries for the
three years ended [date], 20__ and all required Statutory Financial Statements
(as defined in the Purchase Agreement) of the Company and the Subsidiary
Insurance Companies for the year ended [date], 20__]

[FOR FISCAL QUARTER END: Attached hereto are the unaudited consolidated and
consolidating financial statements (including the balance sheet and income
statement) of the Company and its consolidated subsidiaries and all required
Statutory Financial Statements (as defined in the Purchase Agreement) of the
company and the Subsidiary Insurance Companies for the year ended [date], 20__]
for the fiscal quarter ended [date], 20__.]

The financial statements fairly present in all material respects, in accordance
with U.S. generally accepted accounting principles ("GAAP"), the financial
position of the Company and its consolidated subsidiaries, and the results of
operations and changes in financial condition as of the date, and for the [___
quarter interim] [annual] period ended [date], 20__, and such financial
statements have been prepared in accordance with GAAP consistently applied
throughout the period involved (expect as otherwise noted therein).

The Statutory Financial Statements fairly present in all material respects in
accordance with Applicable Accounting Principles as defined in the Indenture)
the financial position of the subject insurance company and have been prepared
in accordance with Applicable Accounting Principles.

         IN WITNESS WHEREOF, the undersigned has executed this Officer's
 Financial Certificate as of this day of , 2003.

** The Company must provide such certificate and financial information for all
of its insurance subsidiary companies, except for PXRE Reinsurance (Barbados)
Ltd. and PXRE Limited; provided, however, if either PXRE Reinsurance (Barbados)
Ltd. or PXRE Limited engages in insurance activity, which insurance activity
exceeds 10% of the aggregate net earned premium of the Company and its
consolidated subsidiaries as a whole in any fiscal year, the entity exceeding
the 10% threshold will, from that point forward, be required to furnish the
Officer's Financial Certificate and financial information pursuant to Annex F.

                                      F-2
<PAGE>

                                 PXRE Group Ltd.

                                 By:
                                    --------------------------------------
                                 Name:
                                      ------------------------------------

                                 PXRE Group Ltd.
                                 Swan Building
                                 26 Victoria Street
                                 Hamilton, HM12, Bermuda

                                      F-3
<PAGE>

                                                                         ANNEX F

            Definitions for quarterly Officer's Financial Certificate

<TABLE>
<CAPTION>
----------------------------------------------------------------------------------------------------------------------
                               ITEM                                           Definition/Formula
----------------------------------------------------------------------------------------------------------------------
<S>                                                      <C>
   NAIC Risk Based Capital Ratio-P&C                     (Total Adjusted Capital/Authorized Control Level Risk-Based
                                                         Capital)/2
----------------------------------------------------------------------------------------------------------------------
   NAIC Risk Based Capital Ratio-Life                    ((Total Adjusted Capital-Asset Valuation
                                                         Reserve)/Authorized Control Level Risk-Based Capital)/2
----------------------------------------------------------------------------------------------------------------------
   Total                                                 Capital and Surplus-Life Common Capital Stock + Preferred
                                                         Capital Stock + Aggregate Write-Ins for other than special
                                                         surplus funds + Surplus Notes +Gross Paid-In and Contributed
                                                         Surplus + Aggregate Write-Ins for Special Surplus Funds +
                                                         Unassigned Funds (Surplus) - Treasury Stock
----------------------------------------------------------------------------------------------------------------------
   Total                                                 Capital and Surplus-P&C Aggregate Write-Ins for Special
                                                         Surplus Funds + Common Capital Stock + Preferred Capital
                                                         Stock + Aggregate Write Ins for other than special surplus
                                                         funds + Surplus Notes +Gross Paid-In and Contributed
                                                         Surplus + Unassigned Funds (Surplus) - Treasury Stock
----------------------------------------------------------------------------------------------------------------------
   Total Class 1 & 2 Rated Investments to                (Total Class 1 + Total Class 2 Rated Investments)/Total
   Total Fixed Income Investments                        Fixed Income Investments
----------------------------------------------------------------------------------------------------------------------
   Total Class 1 & 2 Rated Investments to                (Total Class 1 + Total Class 2 Rated Investments)/Total
   Total Investments                                     Investments
----------------------------------------------------------------------------------------------------------------------
   Total Assets                                          Total Assets
----------------------------------------------------------------------------------------------------------------------
   Return on Policyholders' Surplus                      Net Income/Policyholders' Surplus
----------------------------------------------------------------------------------------------------------------------
   Expense Ratio                                         Other Underwriting Expenses Incurred/Net premiums Earned
----------------------------------------------------------------------------------------------------------------------
   Loss and LAE Ratio                                    (Losses Incurred + Loss Expenses Incurred)/Net Premiums
                                                         Earned
----------------------------------------------------------------------------------------------------------------------
   Combined Ratio                                        Expense Ratio + Loss and LAE Ratio
----------------------------------------------------------------------------------------------------------------------
   Net Premiums Written (annualized) to
   Policyholders' Surplus                                Net Premiums Written/Policyholders' Surplus
----------------------------------------------------------------------------------------------------------------------
</TABLE>

                                                                F-4Prepared and filed by St Ives Burrups

Exhibit 10.16

FOSTER WHEELER INC.

STOCK OPTION AGREEMENT

     THIS STOCK OPTION AGREEMENT (this “Agreement”), dated as of the 4th day of November 2002, between Foster Wheeler Inc., a Delaware corporation, located at Perryville Corporate Park, Clinton, New Jersey (the “Company”) and Bernard H. Cherry (“Optionee”). 

     WHEREAS, the Optionee previously entered into an employment agreement  (“Employment Agreement”) with Foster Wheeler Ltd. (the “Parent”),

     WHEREAS,
    in accordance with the Employment Agreement between Foster Wheeler Ltd. and
    Bernard H. Cherry, the Company wishes to grant to the Optionee an option
to purchase common shares of Foster Wheeler Ltd. 

     NOW, THEREFORE, it is agreed as follows:

1.     Option. Pursuant to
this Agreement and subject to the terms and conditions hereof, the Company hereby grants to
Optionee on November 4, 2002, this non-qualified stock option (“Option”) to purchase
255,000 common shares of Parent at $1.49 per share, which is the mean of the high and low
sale prices of the Common Shares of Parent on the date of grant of this Option.

2.     Exercise of Option.
This Option shall become exercisable (“vest”), in stages.  Except as provided
in Section 4 hereof, a portion of the Option representing 51,000 shares shall vest
on each date immediately preceding each of the first through fifth anniversaries of
November 4, 2002.  This Option expires ten (10) years from the date hereof.

     This Option may be exercised, to the extent exercisable in accordance with this Agreement,  in whole or part, by written notice to the Company, except that this Option shall not be exercisable if, in the opinion of counsel for the Company, exercise of this Option or delivery of shares pursuant thereto might (i) result in a violation of any law or regulation of an agency of government or (ii) have an adverse effect on the listing status or qualification of Parent shares on any securities exchange.  

3.     Payment of Purchase

Price.  Payment for shares as to which this Option is exercised shall be
made at  the time written notice of exercise is given. The option price shall
be paid upon
exercise (i) in cash in U.S. dollars, or (ii) in common shares of Parent owned
of record  by the Optionee and purchased or held for the requisite period of
time as necessary to
 avoid a charge to the Company’s, Parent’s or any of their affiliate’s
  earnings for financial reporting. Such common shares shall be valued at the
 mean of the  high and low sale prices of such shares on the New York Stock Exchange
 on the day of exercise. At the time of receipt
  of common shares upon exercise of the Option, the Optionee shall be required
 to pay to, or as directed by,
the Company in cash any taxes of any kind required by law to be withheld with
 respect to such shares, or make arrangements satisfactory to the Board of Directors
 of the Company
  (the “Board”) regarding payment of such taxes, and the Company and
  Parent  shall have the right to deduct any such taxes from any payment of any
  kind otherwise
   due to the Optionee.

 

4.     Termination of Employment.  Following any termination of the Optionee’s employment, the Optionee shall be entitled to vested options in accordance
 with the provisions discussed below and all unvested options shall expire.

  
a) If the Optionee’s employment is terminated without Cause
(as defined in the Employment Agreement) or by the Optionee for Good Reason (as defined in
the Employment Agreement), and if the termination is within one year of the termination or
 retirement of Raymond J. Milchovich, Optionee
shall be provided full vesting of the granted stock options which Optionee may exercise for a period of
two years following the Termination Date.   If the termination is beyond one year from the
termination or retirement of Raymond J. Milchovich, then the Optionee may exercise only the
then vested stock options for a period of two years following the Termination Date.  All
unvested Options shall expire.

b) In the event of death of the Optionee while an employee of the Company or a subsidiary or an affiliate of the Company or if the Optionee’s employment with the Company or any such subsidiary or affiliate shall terminate by reason of
disability  (as determined by the Compensation Committee or the Parent’s Board,
the Option may be exercised, in the case of death, by the legatee or legatees
of the Optionee under his last will or by the Optionee’s personal representatives or
 distributees, in accordance with the vesting schedule in section 2 hereof after the
 Optionee's death or termination of employment due to disability until the expiration
 date of the Option.

 
c) If the Optionee’s employment with the company or a subsidiary or affiliate of the Company shall terminate by reason of retirement under a pension or retirement plan of the Company or such a subsidiary or an affiliate (or retirement as otherwise determined by the Compensation Committee or the Company Board), the Option, to the extent exercisable in accordance with the vesting schedule in Section 2
hereof as of the date of such termination of employment, may be exercised after
such termination until the expiration date of the Option.

d) In the event the Optionee’s employment is terminated for Cause (as defined
in the Employment Agreement), or the Optionee terminates his employment other than
for Good Reason (as defined in the Employment Agreement), this option, to the extent
unvested shall be immediately forfeited and the remainder of the Option, to the extent
unexercised on the date which is ninety (90) days after such termination, shall be
forfeited.

               Notwithstanding the foregoing provisions of this Section 4, under no circumstances shall this Option be exercised after the expiration date stated in Section 2 hereof.

     5.     Investment Representations.
If at the time of exercise of all or part of the Option the common shares of Parent
 are not registered under the Securities Act and/or there is no current prospectus in
 effect under the Securities Act with respect to the common shares, the Optionee shall
 execute, prior to the issuance of any such shares to the Optionee, an agreement (in
  such form as the Board may specify) in which the Optionee, among other things,
  represents, warrants and agrees that the Optionee is purchasing or acquiring the
  shares acquired under this Agreement for the Optionee’s own account, for
  investment only and not with a view to the resale or distribution thereof, that
   the Optionee has
knowledge and experience in financial and business matters, that the Optionee is
capable of evaluating the merits and risks of owning any such shares purchased or
acquired under this Agreement, that the Optionee is a person who is able to bear
the economic risk of such ownership and that any subsequent offer for sale or
 distribution of any such shares shall be made only pursuant to (a) a registration statement on an appropriate form under the Securities Act, which registration statement has become effective and is current with regard to the shares being offered or sold, or (b) a specific exemption from the registration requirements of the Securities Act, it being understood that to the extent any such exemption is claimed, the Optionee shall, prior to any offer for sale or sale of such
shares, obtain a prior favorable written opinion, in the form and substance satisfactory to the Board, from counsel acceptable to the Board, as to the applicability of such
 exemption thereto.

2

     6.     Recapitalization.  In the event of changes in Parent common shares by reason of share dividends, split-ups or combination of shares, reclassifications, recapitalizations, mergers, consolidations, reorganizations or liquidations, appropriate adjustments shall be made by the Board in (a) the number and class of shares to which Optionee shall thenceforth be entitled upon exercise of this Option, and (b) the price which the Optionee shall be required to pay upon exercise.  Whether any adjustment or modification is required as a result of the occurrence of any of the events heretofore specified, and the amount thereof, shall be determined, in good faith, by the Board, which determination shall be
final, binding and conclusive.

     7. Continued Employment.  So long as the Optionee shall continue to be an employee of Parent, the Company or a subsidiary or affiliate of Parent, the Option shall not be affected by (i) any change of duties or position, or (ii) any temporary leave of absence approved by each employing corporation and by the Board.  Nothing in this Agreement shall confer upon the Optionee any right to continue in the employ of Parent, the Company or a subsidiary or affiliate of Parent or interfere in any way with the right of Parent, the Company or each such subsidiary or affiliate to terminate the Optionee's employment at any time, with or without cause. 

     8. Transferability.  This Option is not transferable by Optionee except by will or by the laws of descent and distribution and is exercisable during Optionee’s lifetime only by him or a court appointed guardian.  No assignment or transfer by Optionee of this Option, or of the rights represented thereby, whether voluntary or involuntary, by operation of law or otherwise, except by will or by the laws of descent and distribution, shall vest in the assignee or transferee any interest or right herein whatsoever. Upon any attempt to assign or transfer this Option, the Option shall forthwith terminate.

     9. Rights as a Shareholder.  Optionee shall not be deemed for any purpose to be a shareholder of Parent except to the extent that this Option shall have been exercised in accordance with this Agreement.  

     10. Corporate Action by Parent.  Existence of this Option shall not impair the right of Parent or its shareholders to make adjustments, recapitalizations, reorganizations or other changes in its capital structure or business, to consummate any merger or consolidation of Parent, to issue bonds, debentures, preferred or prior preference stocks ahead of or affecting the common shares or the rights thereof, to dissolve or liquidate Parent, to sell or transfer all or any part of its assets or business, or to do or take any other corporate act or proceeding it or they might have done or taken if this Option
was not in existence.

3

     11. Change of Control.  During the 60-day period from and after a Change of Control as defined in this Section 11 (the “Exercise Period”), the Optionee shall have the right, whether or not this Option is fully exercisable and in lieu of the payment of the exercise price for the common shares being purchased under the Option and by giving written notice to the Company, to elect (within the Exercise Period) to surrender all or part of this Option to the Company and to receive cash, within 30 days of such written notice, in an amount equal to the amount by which the Change of Control Price per
common share, as defined in this Section 11, on the date of such election shall exceed the exercise price per
common share under the Option (the “Spread”) multiplied by the number of common shares subject to the Option as to which the right granted under this Section 11 shall have been exercised.

     Notwithstanding any other provision of the Plan to the contrary, in the event of a Change of Control, the Option outstanding as of the date such Change of Control is determined to have occurred and not then exercisable and vested shall become fully exercisable and vested to the full extent of the Option. 

     A “Change of Control” shall mean:

     (a)     The acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (a “Person”) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of voting securities of Parent where such acquisition causes such Person to own 20% or more of the combined voting power of the then outstanding voting securities of Parent entitled to vote generally in the election of directors (the “Outstanding Parent Voting Securities”); provided, however, that for purposes of this subsection (a), the following
acquisitions shall not be deemed to result in a Change of Control:  (i) any acquisition directly from Parent or any corporation or other legal entity controlled, directly or indirectly, by Parent, (ii) any acquisition by Parent or any corporation or other legal entity controlled, directly or indirectly, by Parent, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by Parent or any corporation or other legal entity controlled, directly or indirectly, by Parent or (iv) any acquisition by any corporation pursuant to a transaction that complies with clauses (i), (ii) and (iii) of subsection (c) below; and provided, further, that if any Person’s beneficial ownership of the Outstanding Parent Voting Securities reaches or exceeds 20%
as a result of a transaction described in clause (i) or (ii) above, and such Person subsequently acquires beneficial ownership of additional voting securities of Parent, such subsequent acquisition shall be treated as an acquisition that causes such Person to own 20% or more of the Outstanding Parent Voting Securities; or

     (b)     individuals who, as of May 25, 2001, constitute the Board of Directors of Parent (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board of Directors of Parent; provided, however, that any individual becoming a director subsequent to such date whose election, or nomination for election by Parent’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or
threatened election contest with respect to the election or removal of
 directors or other actual or threatened solicitation of proxies or consents
  by or on behalf of a Person other than the Board of Directors of Parent; or

  4

     (c)     the approval by the shareholders of Parent of a reorganization, merger or consolidation or sale or other disposition of all or substantially all of the assets of Parent (“Business Combination”) or, if consummation of such Business Combination is subject, at the time of such approval by shareholders, to the consent of any government or governmental agency, the obtaining of such consent (either explicitly or implicitly by consummation); excluding, however, such a Business Combination pursuant to which (i) all or substantially all of the individuals and entities who were the beneficial owners of the Outstanding Parent Voting Securities immediately prior to such Business
Combination beneficially own, directly or indirectly, more than 60% of, respectively, the then outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation resulting from such Business Combination (including, without limitation, a corporation that as a result of such transaction owns Parent or all or substantially all of Parent’s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Business Combination of the Outstanding Parent Voting Securities, (ii) no Person (excluding any (x) corporation owned, directly or indirectly, by the beneficial owners of the
Outstanding Parent Voting Securities as described in clause (i) immediately preceding or (y) employee benefit plan (or related trust) of Parent or such corporation resulting from such Business Combination, or any of their respective subsidiaries) beneficially owns, directly or indirectly, 20% or more of, respectively, the then outstanding shares of common stock of the corporation resulting from such Business Combination or the combined voting power of the then outstanding voting securities of such corporation except to the extent that such ownership existed prior to the Business Combination and (iii) at least a majority of the members of the board of directors of the corporation resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the
initial agreement, or of the action of the Board of Directors of Parent, providing for such Business Combination; or

     (d)     approval by the
shareholders of Parent of a complete liquidation or dissolution of Parent.

     For purposes of this Agreement, “Change of Control Price" means the higher of (i) the highest reported sales price, regular way, of a common share of Parent in any transaction reported on the New York Stock Exchange Composite Tape or other national exchange on which such shares are listed during the 60-day period prior to and including the date of a Change of Control, or (ii) if the Change of Control is the result of a tender or exchange offer or a Business Combination, the highest price per Common Share paid in such tender or exchange offer or Business Combination; provided, however, that if the Optionee is an officer or director of the Company or Parent and is subject to Section 16(b) of the
Exchange Act and the Option was granted within 240 days of the Change of Control, the Change
of Control Price for the Option shall be the fair market value of the common shares on
the date the Option is exercised or deemed exercised.  To the extent that the consideration
paid in any such transaction described above consists in whole or in part of securities
 or other non-cash consideration, the value of such securities or other non-cash
 consideration shall be determined in the sole discretion of the Board. 

 5

     12.     Administration Disputes.  This Agreement and the Option shall be administered and interpreted exclusively by the Compensation Committee of the Board of Parent, which shall have discretionary authority concerning all matters relating to the Option, and whose actions and decisions shall be final and conclusive.  Any controversy, claim or dispute issues arising out of or relating to this Option shall be
resolved in accordance with the Dispute Resolution Procedure set forth in the Employment Agreement.

     13.     Terms and Conditions.  This Agreement is subject to all terms and conditions of the Employment Agreement.

     14.     Governing Law.  This Agreement and the rights and obligations of the parties hereto shall be governed by the laws of the State of New Jersey without regard to the principles of conflicts of law which might otherwise apply.

     15.     Notice.  Any notice which either party hereto may be required or permitted to give to the other shall be in writing, and may be delivered personally or by mail to the Company at the office of the Secretary of Foster Wheeler Inc., Perryville Corporate Park, Clinton, New Jersey 08809-4000, and to the Optionee at his principal residence as reflected in the records of Parent.

     IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly authorized Officers and Optionee has hereunto set his hand, as of the day and year first above written.

FOSTER WHEELER INC.

  

  

By: /S/ Raymond J.Milchovich

Raymond J. Milchovich

Chairman, President and CEO

/S/ Bernard H. Cherry

Bernard H. Cherry

Optionee

ATTEST:

/S/ Lisa Fries Gardner

 Secretary

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00062-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00062-of-00352.parquet"}]]